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SUMMARY
The aim of this study was to develop a three-dimensional cell culture model to study the growth
factor dependency of a human teratocarcinoma cell line Tera-2 and human skin pigment cells,
and their responses to extracellular matrix (ECM) mediated stimuli.
Malignant Tera-2 cells originally derived from a human germ cell tumor have a remarkable
ability to differentiate in response to retinoic acid (RA) stimulation. The resulting cells are
phenotypically benign neurons. Tera-2 served as a model of differentiation-induced changes in
cell behavior during development.
Human skin melanocytes form a loose network of pigment producing cells in the basal
epidermis where they are exclusively found in contact with the basal layer of keratinocytes and
the basement membrane. Pigment cell nevus represents a local, benign proliferation of
melanocytes. Nevus cells, like malignant melanoma cells, are in many cases able to grow in the
dermis. The differential in vivo localization of these cell types was the reason to use them as a
model to study changes in growth factor and ECM requirements during various stages of
malignant progression.
Type I collagen gel was used as a three-dimensional cell culture lattice. The growth factors of
interest were either mixed into the gel or added as a single spot to form a concentration gradient.
The cells were observed by microscopy and analyzed by immunohistochemistry, Western
blotting, Northern blotting, or flow cytometry.
Undifferentiated Tera-2 cells grew in collagen as tight clusters. FGF-2 induced scattering of the
cells or, when in gradient, directional migration towards the FGF-2 source. After RA induced
differentiation, Tera-2 cells growing in collagen gel started to undergo apoptosis. FGF-2 and
FGF-2 containing ECM preparations promoted the survival but not migration of differentiated
cells. Tera-2 cells express two members of the FGF family, FGF-2 and FGF-4. The expression
of both FGFs was turned off during differentiation in collagen, whereas on the plastic surface of
a tissue culture dish, the expression of FGF-4 only became undetectable.
The results suggest that signaling through FGF receptors is vital for Tera-2 cells. Differentiation
in collagen results in complete extinction of their autocrine stimulatory FGF loops. In vivo, such
differentiation-induced growth factor dependency would result in apoptotic death of the cells
that fail to find adequate FGF stimulation.
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Epidermal melanocytes are dependent on FGF-mediated paracrine signaling from neighboring
keratinocytes. In vitro, unstimulated melanocytes rapidly entered apoptosis when cultured in
collagen gel. Addition of FGF-2 strongly promoted their survival. Dermal nevus cells survived
without exogenous FGF stimulation. Nevus cells were found to produce fairly large amounts of
FGF-2 themselves, while normal melanocytes were almost completely negative. The survival
of nevus cells in collagen was repressed by protamine, an inhibitor of FGF-2 mediated effects.
TGF-1 dramatically accelerated the apoptosis of melanocytes in collagen. Neutralizing
TGF-1 antibodies not only inhibited the effect of exogenous TGF-1 but also improved the
survival of melanocytes even in the absence of exogenous growth factors. This suggests a new
role for TGF- as a mediator of melanocyte apoptosis. FGF-2 was found to counteract the
effects of TGF-. Melanocytes, nevus cells, and melanoma cells were found to produce and
secrete TGF- in cell culture. For nevus cells TGF- acted as a growth inhibitor but not inducer
of apoptosis. Melanoma cells were totally resistant to TGF- effects.
The TGF- induced apoptosis of melanocytes in collagen was found to be associated with
downregulation of the antiapoptotic protein Bcl-2 and an early increase in intracellular
oxidative stress. Antioxidants N-acetylcysteine and ascorbic acid effectively decreased the
oxidative stress and inhibited apoptosis. FGF-2 both increased Bcl-2 and decreased the
oxidative stress. Caspase inhibitors inhibited melanocyte apoptosis in collagen without effects
on Bcl-2 or radical levels.
The results suggest that the balance between inhibitory (TGF- and stimulatory (FGF-2)
growth factors has the potential to regulate the growth, localization, and survival of melanocytes
also in vivo. Autocrine or paracrine TGF- stimulation induces apoptotic death of normal
melanocytes in a collagen environment in the absence of sufficient FGF-2 stimulation. FGF-2
expression and resistance to TGF- mediated apoptosis allow nevus cells and tumorigenic
melanoma cells to survive and grow in the dermis that consists largely of type I and III
collagens.
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INTRODUCTION
Research in cell biology explores fundamental processes that not only underlie the behavior of a
single cell or cell type but also form the basis for functions of tissues and whole organisms. The
aim of biological research is to learn to understand normal biology. However, in many cases it is
possible to learn things about what is normal by studying pathological phenomena. Cancer in its
many appearances has been the favored subject of interest for thousands of scientists and for
decades of time.
Cancer is characterized by a disturbance in cellular growth control. Tissue growth can be
abnormal because of faults in cellular signaling cascades normally leading to quiescence
(growth arrest), differentiation, or apoptosis. Apoptosis, the suicide of aged, damaged or surplus
cells, is important during normal development and maintenance of healthy organs.
Abnormalities of apoptosis have been described in many serious pathologic conditions ranging
from cancer to AIDS.
Normal growth is tightly regulated by extracellular cues that trigger complex intracellular
programs. Each cell has contact with neighboring cells and with the extracellular matrix. Much
of the paracrine signaling between neighboring cells is mediated by growth factor action on
their respective cell surface receptors. In many cases these growth factor signals are mediated
by the extracellular matrix which can guide and restrict growth factor diffusion and in some
cases act as a reservoir of signaling molecules.
The aim of this study was to explore changes in growth requirements and survival of two cell
types: Tera-2, a malignant cell line that can, when properly stimulated, differentiate in vitro into
benign cells, and melanocytes, among which both benign and malignant cells of the melanocyte
lineage were studied. To achieve a controllable system where even subtle changes would be
easily detectable, a model was developed that utilizes type I collagen as an artificial matrix. This
model makes it feasible to compare the growth requirements of cells under conventional and
three-dimensional culture conditions.
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REVIEW OF THE LITERATURE
Extracellular matrix
Functions of the ECM
The extracellular matrix (ECM) is a highly organized meshwork of molecules. The structural
components include collagens, noncollagenous glycoproteins, and proteoglycans. Like the
cement in a brick wall the ECM provides cells with a scaffold that they can attach to. It also acts
as a barrier that insulates tissues, impedes cell migration and regulates diffusion and the
spreading of physiological and non-physiological stimuli. Besides these seemingly passive
functions it serves as a dynamic cellular microenvironment that can mediate information to and
from the cells and store and protect essential regulatory factors produced by the cells. ECM is
actively produced and molded by the cells. The interplay and signalling between cells and ECM
is continuous. The broad spectrum of functions makes it understandable that mutations
affecting ECM components and their normal function can cause a wide range of pathologic
conditions in any organ of the body (for review see Bruckner-Tuderman and Bruckner, 1998;
Aumailley and Gayraud, 1998).
The fine composition of the ECM is under tight regulation and is different in every specific
tissue. Two broad categories of ECM can be distinguished with differing main structural
components, the basement membranes (BM) and the interstitial connective tissue.
Structure of the ECM
The basement membrane
BMs are specialized, sheet-like extracellular matrices. They are secreted by epithelial,
endothelial, and many mesenchymal cells and serve to separate these from the underlying cells
and matrix structures. In different organs BM can have very specialized additional functions
ranging from regulation of gene expression to acting as a molecular sieve. The main
components of BM are type IV collagen, laminin, entactin/nidogen, and heparan sulfate
proteoglycans (HSPGs) (Table 1; for review see Yurchenco and Schittny, 1990).
Type IV collagen molecules are heterotrimers of (IV) chains. Six genetically different chains
(1(IV) to 6(IV)) have been cloned but only the combination 1(IV)22(IV) has been
12
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purified (Brown and Timpl, 1995).
The chains form a triple-helical
structure with several interruptions
that make it comparatively flexible.
Two molecules can interact and bind
each other through the C-terminal
globular noncollagenous domain
(NC1) and four molecules can
tetramerize by lateral association of
the N-terminal 7S-termini. In
addition, certain regions of the triple
helical parts of the molecule can
interact and form a supercoiled
structure. A self-assembly process leads to the formation of a scaffold that is stabilized by
disulfide bonding and covalent cross-linking (Yurchenco and Schittny, 1990).
Laminin (mostly laminin 1) provides another polymeric network in BM. Laminin is a flexible
cruciform glycoprotein (carbohydrate content 12-15%) that consists of three polypeptides, the
larger (c. 400 kDa) A () chain and the two smaller (c. 200 kDa) chains designated B1 () and
B2 (). The terminal globular domains of the arms of laminin molecule are involved in the
attachment of several molecules to dimers and oligomers. The self-assembly of laminin
network is calcium-dependent. The three-dimensional scaffold is an important component of all
BMs. Several cell types interact with laminin that promotes their attachment, spreading and
differentiation (see Aumailley and Rousselle, 1999; Timpl, 1989 for review, Panayotou et al.,
1989). Laminin apparently interacts with type IV collagen network through a bridging
molecule, entactin/nidogen.
Entactin is a dumbbell-shaped glycoprotein with two terminal globules and a connecting
rod-like domain. It binds to the central region of laminin with the COOH-terminal globule and
to type IV collagen apparently with the same domain (Timpl, 1989; Paulsson et al., 1987).
Proteoglycans are present in all BM structures (see Iozzo, 1998 for review). The three most
important mammalian BM proteoglycans are perlecan, agrin, and bamacan. As highly charged
macromolecules, they are probably responsible for the charge-dependent molecular sieving
functions of BM for example in the glomeruli. Perlecan, that carries primarily HSPG side
chains, is a prominent component of the endothelial BMs and it may play a key role in early
Table 1
Main structural components of the ECM
Basement membrane Interstitial connective tissue
Type IV collagen Fibril-forming collagens
Laminins (types I, II, III, V, XI)
Proteoglycans Non-fibrillar collagens
Entactin (types VI, IX, XII, XVI, XIX)
Type VII collagen Elastin
Fibulins Fibrillins
Fibronectin
Vitronectin
Chondronectin
SPARC
Thrombospondin
Tenascin
Proteoglycans
vasculogenesis (Handler et al., 1997). Several heparin-binding growth factors, including
fibroblast growth factor 2 (FGF-2, basic FGF, bFGF) and vascular endothelial growth factor
(VEGF), are involved in the process of vasculogenesis. Perlecan has the potential to store these
growth factors and regulate their diffusion and activity. Agrin is a HSPG primarily found on the
synaptic BM (Tsen et al., 1995; Iozzo, 1998). Bamacan, a chondroitin sulfate proteoglycan, is
found in nearly all of the BMs investigated (McCarthy and Couchman, 1990; McCarthy et al.,
1994). Its functions are poorly known but from developmental studies it has been inferred that
bamacan may inhibit, while perlecan seems to enhance, branching morphogenesis (Iozzo,
1998).
It is not known exactly how BM is connected to the underlying interstitial connective tissue.
Considerable progress has been made during the past few years by studying hereditary
blistering skin diseases caused by mutations in the gene for type VII collagen (see
Bruckner-Tuderman et al., 1999 for review). Anchoring fibrils composed of type VII collagen
extend from the BM to foci of BM components (anchoring plaques) deep in the stroma. On the
ventral surface of BM anchoring fibrils interact with specialized cellular junctional complexes
called hemidesmosomes through another minor BM component, laminin 5. Hemidesmosomes
serve to attach epithelial cells to the underlying BM in complex epithelia such as the skin.
Unlike other laminins, laminin 5 does not bind nidogen and it lacks the self-association domain
needed to form an independent network (see Borradori and Sonnenberg, 1999 for review).
Fibulins , a group of small glycoproteins rich in epidermal growth factor (EGF)-like repeats, are
also thought to be involved in connecting BM networks to the fibrils of the interstitium
(Aumailley and Gayraud, 1998).
The information needed to form such complicated structures as a BM seems, rather surprisingly,
to be intrinsic to the molecules (Yurchenco, 1994). As mentioned above, both type IV collagen
and laminin are able to self-assemble into a three-dimensional network. Grant et al. (1989) have
also shown that structures resembling a BM can be formed by co-incubation of laminin, type IV
collagen, and HSPG at 35°C.
The interstitial connective tissue
The interstitial connective tissue surrounds and is formed by connective tissue cells (Table 1). It
is the major structure determining the mechanical strength and elasticity of tissues like bone,
cartilage, tendons, and dermis. As could be predicted from the extremely varying qualities
14
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represented by these tissue types, there are marked differences in the composition and
molecular architecture of their matrices.
Collagens are the most abundant structural components of the intersitial matrix. The
fibril-forming collagens (types I, II, III, V, and XI) are synthesized as procollagens with large
globular N- and C-terminal propeptides. The enzymatical cleavage of these leads to the
formation of mature collagen (van der Rest and Garrone, 1992). During fibrillogenesis the
collagen molecules are assembled longitudinally to thick fibrils. Type II collagen fibrils are
typical for cartilage. Type I collagen is the major structural protein of most other tissues
including skin, bone and tendon. Varying amounts of type XI collagen is found in association to
type II fibrils and types III and V are found within type I fibrils (Henkel and Glanville, 1982;
Mendler et al., 1989). These minor fibrillar collagens are thought to be involved in regulating
fibril morphogenesis. Collagen fibrils account for the ability of tissues to resist stretching. In
tendon, where the load is longitudinal, the fibrils align longitudinally. In the skin, on the other
hand, the fibers form a seemingly random meshwork but they get aligned during loading.
Non-fibrillar collagens form a rather heterogenous group. Fibril associated collagens with
interrupted triple helix (FACIT, types IX, XII, XIV, XVI, and XIX) are found on the surface of
collagen fibrils possibly facilitating interactions with proteoglycans through their large
extending noncollagenous domains (Brown et al., 1993). Type VI collagen forms a polymeric
microfibrillar network. Glycoasaminoglycan interactions probably connect the type VI
collagen network to other polymers of the ECM but its biological roles are still not fully known
(Bidanset et al., 1992; Burg et al., 1996; Kielty et al., 1992).
Elastin and fibrillins form an important part of the connective tissue matrix. Together they form
the elastic fibers that confer elasticity to tissues. Elastin, a hydrophobic, extensively
cross-linked protein, forms the amorphous part of elastic fibers. It has the property of
rubber-like recoil. Fibrillin microfibrils that form the core of elastic fibers probably have a role
in the assembly of elastin (Mecham and Davis, 1994). Fibrillins form a family of proteins that
consist almost entirely of EGF-like motifs. Several other small proteins are thought to be
involved in the assembly of the elastin/microfibril system (Brown-Augsburger et al., 1996;
Cleary and Gibson, 1996).
Another ECM meshwork is provided by fibronectin. Fibronectin is a large (c. 250 kD)
noncollagenous glycoprotein that forms disulfide linked dimers. Alternative splicing gives rise
to at least 20 variants in man. Fibronectin also forms fibrils but, in contrast to collagen
self-assembly, the polymerization is cell driven. Fibronectin has several binding regions that
15
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interact with cells, heparin, fibrin, and collagens (Hynes, 1990). Mouse embryos defective in
both fibronectin alleles die in utero (George et al., 1993).
Other glycoproteins of the ECM that display adhesive properties include vitronectin,
chondronectin, SPARC, thrombospondin and tenascin (Yamada, 1991).
Proteoglycans form the amorphous mass of interstitial extracellular matrices. They provide the
glue between various networks and, as highly hydrophilic molecules, retain water that is
important for maintaining normal tissue volume. Several classes with different sizes and protein
cores are present in the ECM (see Wight et al., 1991; Iozzo, 1998 for review).
The group of small leucine-rich proteoglycans (protein core of 36-42 kD) includes decorin,
biglycan, fibromodulin, lumican, and epiphycan. The protein core of decorin or fibromodulin
binds to fibrillar collagen. The protein core has also been reported to interact with type VI
collagen, fibronectin, and thrombospondin (Bidanset et al., 1992; Winnemoller et al., 1991;
Winnemoller et al., 1992).
The hyalectans are proteoglycans with a large protein core (100-370 kD). The protein core has
several functional domains including an N-terminal domain that binds hyaluronan, a central
domain that carries the glycosaminoglycan side chains, and a C-terminal region that binds
lectins. Of these, versican has a widespread distribution, while aggregan is mostly expressed in
cartilage, and neurocan and brevican are found almost exclusively in neural tissue (Iozzo,
1998).
Cell-matrix and cell-cell interactions
Cell adhesion is fundamental to formation and maintenance of tissue structure and function.
Changes in adhesive interactions are found early in conjunction with malignant transformation
and metastasis (Takeichi, 1993; Yap, 1998). The environment can regulate cellular functions in
several ways. Receptor molecules for ECM proteins or cellular counter-receptors can mediate
both mechanical stress and ligand specific interactions leading to activation of specific
intracellular signal pathways (outside-in signalling). Vice versa, intracellular events can lead to
changes in the expression and affinity state of cell surface adhesion receptors (inside-out
signalling) (see Aplin et al., 1998 for review). Additionally, neighboring cells secrete and ECM
harbors a multitude of growth factors and other signalling molecules.
The most studied family of adhesion receptors, integrins, are transmembrane heterodimeric
glycoproteins. The family consists of at least 16  subunits and at least 8  subunits which can
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form more than 20 different integrins with distinct ligand binding specificities (Hynes, 1992;
Rosales et al., 1995). For example, adhesion to type I collagen is mediated by 1 integrins,
principally 11, 21, and 31 (Tuckwell and Humphries, 1993), while denatured collagen
is a ligand for v3 (Davis, 1992). Aggregation of integrin molecules by their natural ligands or
monoclonal antibodies induces intracellular accumulation of a multitude of associated proteins
and activation of the JNK, ERK, and MEK pathways (Miyamoto et al., 1995a; Miyamoto et al.,
1995b; Galbraith and Sheetz, 1998). Further, tension applied to the cell through integrins
initiates other signals. Mechanical tension has been reported to induce shifting of ribosomes and
mRNA into focal adhesions, complexes of aggregated integrins and associated proteins
(Chicurel et al., 1998).
Integrins undergo a set of dynamic conformational changes after ligand binding (Loftus and
Liddington, 1997). According to a widely accepted model, the cytoplasmic domain of the 
subunit is inhibitory to the activating  cytoplasmic domain. Ligand binding releases the
inhibition possibly by allowing the domains to separate (Burridge and
Chrzanowska-Wodnicka, 1996; Hughes et al., 1996). Intracellular factors have been shown to
modulate the affinity of integrin receptors to their ligands. Different Ras-related small GTPases
and their downstream effectors can have either positive or negative effects on ligand binding
(Zhang et al., 1996; Hughes et al., 1997).
Cadherins form another important family of cell adhesion receptors. They are transmembrane
proteins with a homologous extracellular domain consisting of multiple repeats of a cadherin
motif (Suzuki, 1996). The “classic” cadherin subfamily includes N-, P- and E-cadherins along
with a dozen other members (Takeichi, 1995). “Classic” cadherins mediate cell-cell adhesion
by homotypic interactions in specific sites called adherence junctions. At these sites the
cadherins of neighboring cells form a zipper-like structure. Another subgroup of cadherins is
involved in intercellular interactions that take place in desmosomes (Cowin and Burke, 1996).
The intracellular domains of cadherins interact with a group of proteins called catenins.
Catenins mediate interactions of adherens junctions with the actin cytoskeleton (Cowin and
Burke, 1996). Cadherins are critical for maintenance of normal tissue architecture. Several
malignancies are associated with loss of normal cadherin expression or function (Risinger et al.,
1994; Oda et al., 1994; Yoshiura et al., 1995; Berx et al., 1996). Considerably less is known
about the role of cadherins in signal transduction.
The immunoglobulin superfamily of cell adhesion molecules (Ig-CAMs) is a diverse group of
proteins that contain one or more Ig folds. A typical example is NCAM, which contains five Ig
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folds in its extracellular part. NCAM functions as a homotypic adhesion receptor in the nervous
system (Edelman and Crossin, 1991). Several other Ig-CAMs are present in developing and
mature nervous tissue and are thought to be involved in axon guidance and formation and
maintenance of neural connections (Baldwin et al., 1996). Ig-CAMs also have a critical role in
the immune system. They mediate several aspects of immune response from antigen
recognition and presentation to leukocyte trafficking (Dustin and Springer, 1991; Rosales and
Juliano, 1995; Springer, 1995).
Selectins form a small group of adhesion receptors. They mediate heterotypic cell-cell
interactions like the adherence of leukocytes and platelets (L-selectin and P-selectin) to
endothelium (E-selectin) during inflammation (Lasky, 1995; Rosen and Bertozzi, 1994; Tedder
et al., 1995).
ECM resident growth factors
Several growth factors bind to ECM either directly or via specific binding proteins. The largest
group of ECM associated growth factors binds to HSPG or heparin. Heparan sulfates are highly
heterogeneous and their growth factor binding ability seems to be affected by remarkably small
critical modifications. For example, FGF-2 binding to HSPG is promoted by 2-O-sulfation of
the uronic acid (Faham et al., 1996; Maccarana et al., 1993), whereas N- or 6-O-sulfation of
glucosamine inhibits binding (Ernst et al., 1995). Other members of the FGF family also bind to
HSPG but the critical residues are not conserved suggesting that they may bind to different
HSPG substructures (Faham et al., 1996). Treatment of tissue preparations with heparin,
heparanases or proteases releases FGF-2 from the matrix in a biologically active form
(Flaumenhaft and Rifkin, 1992). HSPG protects FGF from proteolytic degradation and
inactivation by heat and extremes of pH (Saksela et al., 1988). Cell surface HSPGs also bind to
FGF receptor molecules with high affinity and act as modulators of FGF-receptor interactions.
This modulation can be either stimulatory or inhibitory (Kan et al., 1999; Plotnikov et al., 2000).
Other growth factors that interact with HSPG include the hepatocyte growth factor family
(Mizuno et al., 1994), platelet derived growth factor (PDGF) (Raines and Ross, 1992), VEGF
(Park et al., 1993), heparin-binding EGF-like growth factor (Raab and Klagsbrun, 1997), and
several hematopoietic cytokines, like interleukin 3 (IL-3) and granulocyte macrophage growth
factor (GM-CSF) (Roberts et al., 1988). TGF can bind to HSPG via an accessory protein
(Bützow et al., 1993).
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Growth factors can associate with other ECM components besides HSPG. TGFs are secreted
as latent, inactive complexes. During secretion, TGF is cleaved from its propeptide LAP
(latency associated peptide) but LAP remains associated with TGF by noncovalent
interactions (Gentry et al., 1988; Sha et al., 1989; Dubois et al., 1995). This complex interacts
with a group of proteins called latent TGF-b binding proteins (LTBP). LTBPs are highly
homologous to fibrillins, which are major constituents of the connective tissue microfibrils.
They mediate the association of latent TGF with the matrix (Miyazono et al., 1988; Kanzaki
et al., 1990; Tsuji et al., 1990; Taipale et al., 1994). TGF can be released and activated by
proteolysis (Taipale et al., 1992; Taipale et al., 1995). Active TGF also has interactions with
ECM components like the protein core of small leucine-rich proteoglycans (Hildebrand et al.,
1994).
PDGF-AB and -BB bind to SPARC. The expression of SPARC is especially high in tissues
undergoing remodeling or repair (Porter et al., 1995). The binding of complexed PDGF to its
receptors is inhibited but the complex seems to dissociate in the mildly acidic conditions created
during inflammation and tissue damage.
Insulin-like growth factors associate with a group of binding proteins (IGFBPs) some of which
are components of the connective tissue matrix (Jones et al., 1993). Also, tumor necrosis factor
 (TNF has been shown to have interactions with fibronectin (Alon et al., 1994).
Matrix association can serve several functions. It allows generation of rapid and highly
localized signals in situations like tissue damage and microbial invasion. The low affinity
binding sites of the matrix enable formation of growth factor gradients in tissues. This facilitates
for example the directional migration of certain cell populations during development. Also,
growth factors of the ECM can have important regulatory feedback signal functions during
tissue degradation and remodeling (Taipale and Keski-Oja, 1997).
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Regulation of cell growth and survival
Cell multiplication
Multicellular organisms are composed of millions of cells. They all are progeny of one cell, the
fertilized oocyte, which during development form highly specialized subpopulations. In most
cases cells loose multipotency during the process of differentiation and are not able to switch
into another cell type anymore. Certain cells, like neurones, almost completely stop
proliferating while several other types undergo continuous divisions throughout the life of the
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Figure 1. The cell cycle. A simplistic diagram depicting changes in the activity of cyclin-Cdk complexes and pRb
during cell cycle progression. D-type cyclins are the key regulators of G1 progression. They are induced as a
response to mitogenic stimulation and are rapidly degraded when mitogens are withdrawn. The cyclins assemble
with the catalytic partners, Cdk 4 and Cdk 6. Cdk Inhibitors (CKI) p21Cip1 and p27Kip1 act as assembly factors.
The cyclin D-Cdk-CKI complex is active and serves to sequester CKIs that would otherwise inhibit other
cyclin-Cdk complexes. Assembled complexes enter the cell nucleus and are phosphorylated by a Cdk-activating
kinase (CAK). The most important function of active cyclin D-Cdk is to phosphorylate Rb. Rb phosphorylation
releases transcription factor E2F, which leads to transcription of several genes necessary for DNA synthesis,
including cyclins E and A. Cyclin E-Cdk 2 becomes active and completes the phosphorylation of Rb on several
additional sites. The cell is then triggered to enter the S-phase and start DNA synthesis. CyclinA- andB-dependent
Cdks maintain Rb phosphorylation until the end of mitosis. Cyclin A-Cdk 2 is essential for progression through
S-phase and again for the G2/M transition. Cyclin B-Cdk 1 complexes accumulate in an inactive state during S and
G2 phases. At the end of G2, Cdc25CdephosphorylatesCdk 1, which triggers entry tomitosis. CyclinsA andB are
degraded during mitosis, Rb becomes dephosphorylated, and another cycle can begin. Checkpoints indicate
critical steps of the cell cycle where disturbances (ex.g. DNA damage) can trigger arrest. Based on Hunter and
Pines, 1994; King et al., 1994; Sherr, 1994; Sherr and Roberts, 1999.
organism. Cells like endothelial cells of the dermal capillaries proliferate only slowly but
increase their proliferation rate for example during the process of wound healing.
The sequence of events during division of mammalian cells is described as the cell cycle (Fig.
1). Resting cells outside the cycle are in G0-phase. When properly stimulated they enter the cell
cycle that consists of four phases. In G1-phase the cell is under the influence of extracellular
signals that control its progression to the next phase. When the cell proceeds through the
restriction point (R), it is committed to go through the rest of the cell cycle. The cell also
prepares itself for DNA synthesis by synthesizing the necessary components. In S-phase the
cellular DNA is doubled by copying the whole genome. In G2-phase the cell prepares for
mitosis, the M-phase. After mitosis it returns to G1 and another decision has to be made whether
to halt or to continue. The duration of a complete cycle is different in each cell type (Pardee,
1989; Sherr, 1996; Hamel and Hanley-Hyde, 1997).
The cell cycle machinery is regulated by sequential activation of cyclin-cyclin dependent kinase
(Cdk) complexes. Formation of the complexes and regulation of their activity is highly specific.
External and internal cues regulate the activation and inactivation of specific cyclin-Cdk
complexes (reviewed in Pines, 1995). These, in turn, have essential roles in the transition of the
cells from one cell cycle state to the next one. For instance, the regulation of D-type cyclins is
important in transition through the restriction point, and their activity depends on the presence
of certain growth factors (reviewed in Sherr, 1994). The signal routes leading from the
extracellular growth factors to the cell cycle proteins are very complex and only partially
known.
Fibroblast growth factors (FGFs) form a large group of at least 17 structurally related and
predominantly growth stimulatory factors (see Szebenyi and Fallon, 1999 for review). The
prototype member of the group, FGF-2, is found ubiquitously in mammalian tissues from where
it can be quickly mobilized when necessary. FGF signaling is mediated by specific high affinity
cell surface receptors coded by a family of at least 4 distinct fgfr genes (Coutts and Gallagher,
1995). Alternatively spliced transcripts of fgfr genes extend the complexity of the FGFR protein
family. Each variant has a distinctive specificity profile (Table 2; Ornitz et al., 1996, Plotnikov
et al., 2000). The binding to FGFRs is also affected by cell surface HSPGs (Vlodavsky et al.,
1996). HSPGs bind to the self-associated oligomers of the FGFR ectodomain to form a complex
that will bind FGF (Kan et al., 1996, Wang et al., 1997). Cell type specific HSPGs modulate the
ligand specificity of the FGFR complex, and modify the ability of the four FGFRs to bind the
large repertoire of FGFs (Kan et al., 1999). FGF binding leads to receptor transphosphorylation
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in the intracellular tyrosine kinase domain (Neilson and Friesel, 1996). The phosphorylation
steps are essential for mediating many FGF functions (Itoh et al., 1996; McFarlane et al., 1996;
Saffell et al., 1997). However, it has been convincingly shown that FGFRs also mediate
internalization of the FGF ligand. Several FGFs contain a nuclear localization signal sequence
and for example FGF-2 has been reported to translocate to the nucleus in G1 (Kilkenny and Hill,
1996). Thus, FGFs may have functions that involve signalling pathways distinct from those
activated at the cell surface.
Several signaling pathways lead down from FGFRs (Fig. 2). It seems that differences in
downstream signaling exist between the different receptor molecules (Kanai et al., 1997;
Reichman-Fried and Shilo, 1995; Vainikka et al., 1996). The signaling pathway that is thought
to mediate the proliferation effects of FGFs is described here in short. When activated, FGFR1
phosphorylates FRS2 (FGFR substrate) docking molecules (Kouhara et al., 1997). The
phosphorylated FRS2 binds directly to the Grb2-Sos complex that mediates interactions with
Ras. Membrane associated Ras recruits Raf-1 that functions as a mitogen activated protein
kinase kinase kinase (MAPKKK). This leads to sequential activation of MAPKK (MEK), and
MAPK (Ferrell, 1996). The Ras-MAPK pathway regulates cyclin D expression and links FGF
stimulation to the cell cycle machinery (Sherr and Roberts, 1999; Aktas et al., 1997). In vivo, the
set of activation steps is very complex and several parallel MAPK pathways probably exist.
FGFRs also activate other pathways leading to stimulation of PLC-, PKC, IP3, and Ca2+
release (see Klint and Claesson-Welsh, 1999 for review).
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Table 2
Specificity of FGFR-FGF interactions
FGF regulates the expression of a
multitude of genes. They include
immediate early response genes,
delayed early response genes,
homeobox genes, patterning
genes, growth factors and their
receptors, proteases, protease
activators and inhibitors, matrix
proteins etc. (see Szebenyi and
Fallon, 1999 for review). The
regulated genes are often
cell-type specific.
TGFs comprise a family of
multifunctional polypeptides that
regulate the growth of epithelial,
endothelial, and hematopoietic
cells (see Massagué, 1996;
Massagué, 1998; Bonewald, 1999
for review). Three different
subtypes, TGF1, TGF2, and
TGF3 with overlapping
biologic functions have been
described in mammals. In
epithelial and endothelial cells
they cause growth arrest to the G1-phase of the cell cycle. As explained above, TGF activity
is regulated by its association to LAP (latency associated peptide). The activation of secreted
TGF- is the critical step for expression of its biological effects. Active TGF can bind to
specific cell surface receptor molecules (Fig. 3). It is thought first to associate with a cell surface
binding factor betaglycan (López-Casillas et al., 1991; López-Casillas et al., 1993;
López-Casillas et al., 1994). Betaglycan presents TGF to type II TGF receptor, a
constitutively active serine/threonine protein kinase, and a complex is formed between these
two. The complex is bound by type I receptor that becomes phosphorylated. The
phosphorylated type I TGF receptor is activated and propagates the signal further (Wrana et
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Figure 2. FGF receptor signaling. FGF binds to its receptor (FGFR)
facilitated by heparan sulfate proteoglycan (HSPG) interactions.
Several signaling pathways lead down from the activated FGFR. Some
of the interactions involved in mitogen activated protein kinase
(MAPK) and phospholipase C- (PLC-) pathways are shown. Ligand
binding leads to transphosphorylation and activation of FGFR. The
adaptor protein FGF receptor substrate 2 (FRS2) becomes tyrosine
phosphorylated at several sites. Both the Grb2-Sos complex and shp2
adaptor protein are needed for sustained activation of the MAPK
pathway. FGFR activation also leads to binding and tyrosine
phosphorylation of PLC-. Activated PLC- hydrolyses
phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 generation
leads to release of Ca2+ from intracellular stores and DAG
accumulation leads to activation of protein kinase C (PKC) family
members. Based on Klint and Claesson-Welsh, 1999; Szebenyi and
Fallon, 1999; Carpenter and Ji, 1999; Garrington and Johnson, 1999.
al., 1992). The intracellular downstream
signalling is at least partly mediated by
Smad proteins. The Smad pathway leads
to the nucleus where the involved
complexes regulate the expression of
target genes (Heldin et al., 1997). Several
mechanisms for TGF-mediated cell
cycle arrest have been suggested. TGF
can downregulate the expression of c-myc
proto-oncogene and suppress the
phosphorylation and thus the inactivation
of the retinoblastoma (Rb) tumor
suppressor protein (Laiho et al., 1990). Rb
binds several transcription factors and
represses their activity (Wang et al., 1994).
In various studies TGF has also been
shown to suppress the activity of
cyclin-dependent kinases Cdc2 (Cdk1)
(Howe et al., 1991), Cdk2 (Koff et al., 1993) and Cdk4 (Ewen et al., 1993). The function of these
kinases is important for cell cycle progression. TGF can also induce the expression of cyclin
dependent kinase inhibitors p15Ink4B (Hannon and Beach, 1994), p21Cip1 (Li et al., 1995),
and p27Kip1 (Polyak et al., 1994).
Modes and regulation of cell death
Many cells and tissues of a multicellular organism are under constant wear and tear. In
particular, the epithelial cells of skin and intestine are exposed to mechanical and chemical
irritation and, in the case of skin, also radiation. As a consequence, the epithelial cells have to be
replaced frequently. Dead or old cells are shed from the surface and division of basal cells
produces new ones. Since epithelia are often exposed to genotoxic stimuli, this process is an
important defence against accumulation of genetic mutations that could eventually lead to
development of cancer. Elimination of cells is also necessary during development of an
organism, when cells with definite functions during embryogenesis are not needed in the mature
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Figure 3. TGF- receptor signaling. TGF- binds to type II
receptor (RII) either directly or facilitated by its association
to betaglycan (RIII). The complex recruits type I receptor
(RI) by means of the bound TGF-. The constitutively active
RII serine/threonine kinase phosphorylates RI, which leads
to signal transduction. A downstream Smad pathway is
thought to mediate at least part of TGF- effects. Based on
Lin and Lodish, 1993;Wrana et al., 1992;Wrana et al., 1994;
Zhang and Derynck, 1999.
organism. In some cases dead cells serve a specific function (e.g. cornified epithelium) (Ellis et
al., 1991, Fesus et al., 1991).
Cell death was recognized as a normal part of
development and homeostasis about fifty
years ago (Glücksmann, 1950). The
pathologic form of cell death, necrosis,
occurs in response to a variety of conditions,
including hyperthermia, hypoxia, ischemia,
complement attack, metabolic poisons, and
direct cell trauma (Schwartzman and
Cidlowski, 1993) usually leading to
destruction of the plasma membrane or the
biochemical supports of its integrity.
It gradually became evident that there is a
distinct form of naturally occurring cell death
that uses pathways and mechanisms quite
different from necrosis. This type of cell
death deletes cells that have become useless
or harmful to the organism. It followed a
certain defined pattern of events (a program)
that seemed to be genetically coded in the
cells and hence the concept of programmed
cell death arose. Subsequently, the terminal
phase of programmed cell death was termed apoptosis, an ancient Greek word for the falling off
of leaves from trees (Kerr et al., 1972). Apoptotic cells show distinctive morphologic features
(Fig. 4). The earliest changes include loss of cell junctions and plasma membrane extensions.
The cytoplasm and nuclear chromatin condense. The DNA starts to degrade producing
oligonucleosomal fragments. Later, the cell breaks into membrane-bound pouches called
apoptotic bodies. The apoptotic bodies are phagocytozed by nearby cells that can be members of
the mononuclear-phagocyte system or just normal neighboring cells (Arends et al., 1990;
Walker et al., 1988). The membrane integrity of apoptotic bodies and their rapid phagocytosis
prevent the generation of an inflammatory reaction. Lack of inflammation is one of the
hallmarks of apoptosis in vivo since it facilitates cell elimination without injury to the
surrounding tissue (Wyllie et al., 1980). It is also one of the greatest obstacles of accurately
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Figure 4. The morphological changes during
apoptotic death. A characteristic pattern of
morphological changes can be detected in most cases of
apoptosis. They include 1) loss of extensions and cell
rounding, 2) blebbing of the cell membrane and
shrinkage of the nucleus and cytosol, 3) segmentation of
the nucleus and cytosol, and 4) lysis that is very similar to
necrosis. In vivo, the remnants of apoptotic cells are
normally phagocytozed rapidly and lysis does not take
place. Based onKroemer et al., 1995;Willingham,1999.
quantitating apoptosis in vivo. In tissues apoptosis mostly appears asyncronously and as the
cells are phagocytozed quickly afterwards only a few can be detected at each time although
apoptosis can be quite abundant in the tissue (Willingham, 1999).
The mechanisms of apoptosis have been studied extensively. The nematode Caenorhabditis
elegans has provided an excellent model system (Ellis et al., 1991). The genes controlling
programmed cell death in C. elegans are known in detail. As research has moved over to more
complex organisms like mammalians, it has become clear that the same gene families exist but,
while they consist of a few genes in C. elegans, they are extremely complex in mammalians.
Apoptosis is the most common form of cell death. The apoptotic stimuli include a variety of
both physiological death signals and pathological factors. The stimuli are cell type specific so
that for example the same growth factor that is needed for survival of a given cell type induces
death in another. The initial steps during the start of the death program are tightly regulated and
complex but the final mechanism seems to be common.
Different death signals converge into two main pathways of apoptosis initiation. One pathway
involves the so-called death receptors. Death receptors are a subfamily of transmembrane
receptors with two to four cysteine rich extracellular domains and a conserved cytoplasmic
sequence called death domain (DD). The prototype death receptor tumor necrosis factor
receptor (TNFR) binds its ligand TNF (see Bazzoni and Beutler, 1996 for review). Almost all
cells carry TNFR and are therefore potential targets for its effects. It seems, however, that
triggering of apoptosis by TNF- is in most cells suppressed by inhibitory proteins. Since
certain oncogenes activated during tumorigenesis render cells sensitive to TNF or other
death ligands like TRAIL (TNF related apoptosis inducing ligand), these factors could
potentially be used to kill tumor cells selectively. Intensive research is going on to find ways to
benefit from this remarkable feature. Upon ligation, the DD domain of death receptors binds a
cytoplasmic adaptor protein called FADD (Fas associated death domain) by DD-DD
interactions. FADD recruits caspase 8 by homotypic interactions through another conserved
domain called DED (death effector domain). Caspase 8 is activated by autoproteolysis and
initiates a cascade leading to activation of downstream effector caspases (cysteinyl aspartate
specific proteases), specific cellular proteinases involved in execution of apoptosis (Chinnaiyan
et al., 1996; Los et al., 1999; Wehrli et al., 2000; Griffith and Lynch, 1998).
Another apoptosis pathway involves the participation of mitochondria. Several mechanisms can
lead to dysfunction and leakiness of mitochondria. A variety of apoptotic stimuli mediate their
effects through Bcl-2 family of proteins (see Gross et al., 1999 for review). Bcl-2 family
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includes both pro- as well as anti-apoptotic molecules. The expression of such molecules can be
under regulation of a specific survival factor or apoptotic factor, respectively. Following a death
signal, the pro-apoptotic members undergo changes that enable them to target and integrate into
the mitochondrial outer membrane (Hsu et al., 1997; Goping et al., 1998). This leads, among
other things, to release of mitochondrial cytochrome c to the cytoplasm (Desangher et al.,
1999). Together with dATP cytochorome c activates the adaptor protein Apaf1 that, in turn, can
bind and activate the zymogen form of caspase 9 (Li et al., 1997; Los et al., 1999). Mitochondria
can be damaged by several other mechanisms besides the action of pro-apoptotic Bcl-2 family
members. For example, radiation and changes in certain homeostatic enzyme activities can lead
to accumulation of intracellular reactive oxygen species. Oxygen radicals as such damage
several types of biological membranes and cause mitochondrial leakiness as well as dysfunction
of other cellular organelles (see Clutton, 1997 for review).
Both of these pathways lead to activation of caspases. Although there are indications of
caspase-independent apoptosis, they are considered by many to be the essential components of
most, if not all apoptotic pathways. Caspases comprise a family of more than a dozen members
that can promote apoptosis (Los et al., 1999). As a result of activation they cleave several
cellular targets (see Wolf and Green, 1999 for review). The first caspase targets include pro- and
anti-apoptotic proteins (Cohen, 1997; Nicholson and Thornberry, 1997; Cryns and Yuan,
1998). This leads to signal amplification and inhibitor inactivation. Caspases also cleave
structural proteins of the nucleus and cytoskeleton which probably promotes packaging of the
cell to apoptotic bodies and engulfment by phagocytes (Cohen, 1997; Nicholson and
Thornberry, 1997; Cryns and Yuan, 1998; Gohring et al., 1997). A third group of caspase
substrates include homeostatic proteins like enzymes and factors necessary for protein and
nucleic acid synthesis (Cohen, 1997; Nicholson and Thornberry, 1997; Cryns and Yuan, 1998).
Caspases seem to act on the final apoptotic pathway and inhibition of their activity by specific
peptide inhibitors can in many cases effectively stop the progression of apoptosis and the cells
survive. This further emphasizes their central role in the execution of apoptotic cell death.
Oxidative stress has been implicated in apoptosis, although there still is controversy regarding
its importance. Normally, a fine balance exists between cellular oxidants and their defence
mechanisms. During normal aerobic conditions many redox reactions produce highly reactive
intermediates. These reactive oxygen species (ROS) can also have beneficial roles in the cell
and are mostly neutralized by specialized cellular enzymes and antioxidants. If ROS are
produced in excess or the neutralization mechanisms are hampered the cell suffers from
oxidative stress. In extreme cases this leads to severe damage and necrosis (Duvall and Wyllie,
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1986). Less severe oxidative overload causes lipid peroxidation, loss of calcium homeostasis
and alterations of metabolic pathways (Slater, 1987). Increasing evidence shows that in certain
situations these changes mediate apoptotic death of the cell. ROS have been suggested to lead to
apoptosis in response to several stimuli including ionizing radiation, certain chemicals and
chemotherapy agents, and in some cases serum or growth factor deprivation (see Anderson et
al., 1999 for review).
Cancer-dysregulation of cell growth and survival
Mature, normal tissues are characterized by a homeostatic balance between cellular
proliferation and cell death. Imbalance leads to development of disease. Malignant cells most
often have disturbances in both of these processes leading to uncontrolled multiplication and
growth. On the other hand, excessive cell death can result from acquired or genetic conditions
that lead to accumulation of signals that induce apoptosis (see Thompson, 1995 for review). In
AIDS, the HIV infection leads to depletion of CD4+ T cells by apoptosis (Ameisen and Capron,
1991; Groux et al., 1992; Gougeon and Montagnier, 1993). Several neurodegenerative
disorders are characterized by the gradual loss of a subset of neurons by apoptosis (Isacson,
1993; Heintz, 1993). These include Alzheimer’s disease, Parkinson’s disease, amyotrophic
lateral sclerosis (ALS), retinitis pigmentosa, spinal muscular dystrophy and various forms of
cerebellar degeneration.
The apoptotic pathways of cancer cells are not fully unfunctional and many treatments are
targeted to inducing apoptosis in malignant cells. These include both radiation treatments and
most of the chemotherapeutic drugs. The cumulation of genetic lesions can ultimately lead to
development of cancer cells that are resistant to these therapies as well as motile and invasive
enough to metastasize. The importance of apoptosis in defence against malignancies is reflected
in the several aberrations of the apoptotic pathways found in cancer cell lines and tumors in vivo
(see Jäättelä, 1999; Lyons and Clarke, 1997 for review).
The expression of c-Myc proto-oncogene is elevated in many human tumors (Spencer and
Groudine, 1991). Over-expression studies have shown that c-Myc alone can drive cells into
continuous proliferation even in the absence of normal mitogenic stimulation (Eilers et al.,
1989; Evan et al., 1992). However, when c-Myc over-expressing cells are cultured in low
serum, their numbers stabilize despite of frequent mitoses (Evan et al., 1992; Askew et al.,
1991). The discrepancy is explained by a dramatic increase in apoptosis. Thus, it seems that a
genetic lesion causing overproduction of c-Myc is not sufficient for cell transformation.
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Together with other mutations causing changes in apoptotic pathways, it has been proven to
cause direct tumorigenesis (Amundadottir et al., 1996; Santoni-Rugiu et al., 1996).
Additionally, although apoptosis takes place and limits the rate of growth of c-Myc
over-expressing tissues, increased cell turnover means that the probability of subsequent
mutations arises and places selective pressure upon mutations that block apoptosis (Lyons and
Clarke, 1997).
Bcl-2 was initially identified as highly overexpressed protein in follicular lymphoma
(Tsujimoto et al., 1984). In the chromosomal translocation t(14;18) the bcl-2 gene is
translocated into the immunoglobulin heavy chain locus. It was soon found out that, unlike
other oncogenes known at that time, it did not stimulate proliferation but increased cell survival
by inhibiting apoptosis (Vaux et al., 1988). Recently, several transgenic Bcl-2 overexpressing
mice strains have been engineered. These mice are prone to develop lymphomas but only after a
long latency period (McDonnell et al., 1989; McDonnell and Korsmeyer, 1991). In analogy to
c-Myc, Bcl-2 alone doesn’t seem to be able to cause tumorigenesis. It leads to impaired
apoptosis, though, and facilitates subsequent mutations that induce cellular proliferation.
Rather unexpectedly, in at least human breast carcinoma (Leek et al., 1994; Joensuu et al., 1994;
Silvestrini et al., 1994; Hurlimann et al., 1995) and colon carcinoma (Watson et al., 1996;
Sinicrope et al., 1995; Ofner et al., 1995; Baretton et al., 1996) high Bcl-2 expression has been
shown to correlate with improved disease-free and overall survival. The controversy is at least
partly explained by the ratio between anti- and proapoptotic members of the Bcl-2 family. In
breast and gastrointestinal cancers Bax expression or Bax/Bcl-2 ratio correlate with longer
survival and better response to therapy (Krajewski et al., 1995; Ogura et al., 1999). Another
explanation is that Bcl-2 is also an inhibitor of cell cycle progression (Huang et al., 1997). It
probably rescues cancer cells carrying otherwise lethal DNA damage but it also slows down
their cycling until accumulating mutations provide other ways to protect the cells against
apoptosis. After this the selection pressure favors cells that have lost Bcl-2 expression.
Loss of function of tumor suppressor gene p53 is frequently found in association with almost all
human tumors (Hollstein et al., 1991; Beroud and Soussi, 1998). p53 regulates both cell cycle
and apoptosis. DNA strand breaks following for example UV radiation induce p53
accumulation (Liu et al., 1994). p53 activates the transcription of several genes involved in
DNA repair, growth arrest, and apoptosis. If the damage is too extensive to be repaired, the cell
dies. If p53 activity is lost the cells carrying damaged DNA survive and the numbers of mutation
bearing cells increase (Yuan et al., 1995). Genetically engineered p53 -/- mice develop
lymphomas and sarcomas soon after birth. Also heterozygous p53 +/- mice are prone to develop
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tumors but only after a longer latency (Purdie et al., 1994; Jacks et al., 1995). Also the +/- mice
are very susceptible to tumors and double strand chromosomal breaks after exposure to ionizing
radiation (Lee et al., 1994). p53 is important for protection against UV induced skin cancer
(Ziegler et al., 1994). Sunburn keratinocytes enter apoptosis p53 dependently. Cells with
unfunctional p53 acquire lesions in their genome and are predisposed to malignancy. In
melanoma cells, other mechanisms besides p53 pathway have been shown to control UV
responses (Haapajärvi et al., 1999).
Another response to cellular stress is mediated by a group of specialized stress proteins called
heat shock proteins (Hsps). Hsps were first identified on the basis of their synthesis after
exposure of cells to elevated temperatures (Landry et al., 1982). Induced endogenous
expression or overexpression by gene transfer confers resistance to heat stress (Li et al., 1991;
Landry et al., 1989). Hsps function as chaperones and probably mediate their effects by
inhibiting heat induced denaturation and aggregation of cellular proteins (Nollen et al., 1999).
Hsp70 and Hsp27 have been shown to protect cells from several other apoptotic stimuli besides
heat (Jäättelä et al., 1992; Simon et al., 1995; Bellman et al., 1996; Mosser et al., 1997; Jäättelä
et al., 1998). The exact mechanisms are not known. Hsp70 has been shown to be able to inhibit
apoptosis even after the activation of effector caspases, a step that has previously been
considered “the point of no return” (Jäättelä et al., 1998). Hsp27 seems to protect cells from
ROS both by increasing glutathione levels and by neutralizing their effects by its chaperone
activity (Préville et al., 1999). Several human tumors have been reported to express Hsp70 and
some also Hsp27 (see Jäättelä, 1999 for review). With some exceptions, they are typically
associated with poor prognosis.
Recently, a group of Inhibitor of Apoptosis Proteins (IAP) has been found originally from
baculovirus infected cells (see LaCasse et al., 1998 for review; Crook et al., 1993; Birnbaum et
al., 1994). Most of the IAPs seems to mediate their effects by inhibiting the functions of
activated effector caspases (Roy et al., 1997; Deveraux et al., 1998). The cancer-associated
member of the family, survivin, is expressed in normal tissues only fetally and in almost all
cancer cell lines and primary carcinomas studied so far (Ambrosini et al., 1997). Its prognostic
value remains to be investigated but there are indications that it favors the cycling of cells with
an aberrant genome (Li et al., 1998).
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Embryonal carcinoma - a model for cancer and for cell differentiation
The origin of embryonal carcinoma cells
Teratoma is a germ cell tumor that often consists of an array of more or less organized tissues.
The tumor mass contains hair, skin, myocardium, or endocrine tissues, sometimes even a
completely formed organ like the eye (Sergi et al., 1999). The malignant form of teratoma is
called teratocarcinoma. Teratocarcinomas include nests of undifferentiated stem cells,
embryonal carcinoma (EC) cells, that have at least partly retained the ability to differentiate into
various tissues. EC cells have been shown in several aspects to be similar to the embryonal stem
(ES) cells of the inner cell mass and primitive ectoderm (Solter and Damjanov, 1979; Martin,
1980). It could be shown in a mouse model that when pluripotent EC cells were placed into a
normal blastocyst, it developed into a chimeric mouse with normal and EC cell derived tissues
(Brinster, 1974; Papaioannou et al., 1975). It has also been shown that murine primordial germ
cells transform spontaneously into EC-like cells when cultured in vitro under suitable
conditions (Matsui et al., 1992). Most EC cell lines probably represent a degenerate form of ES
cells and have limited capability to differentiate.
The germ cell tumors are caused by an unknown mutation in the primordial germ cells during
early development. The abnormal cells can remain dormant for long periods of time until they
start proliferating, without entering meiosis like normal germ cells. They form a teratoma or a
carcinoma in situ that can develop into a seminoma or transform into EC cells.
Tera-2 cell line
The most widely used pluripotent human EC cell line is Tera-2 and its clonal derivatives. Tera-2
was originally derived from a lung metastasis of a testicular teratocarcinoma (Fogh and
Tremple, 1975). Later, another subline called NTera-2 was derived by passaging Tera-2
through athymic mouse (Andrews et al., 1984) in which it causes tumors.
Retinoic acid treatment induces the differentiation of Tera-2 cells into neurons and other cell
types yet to be specified. Simultaneously, the cells lose their tumorigenic potential (Dmitrovsky
et al., 1990). The commitment to differentiate takes place within a few days of exposure to
retinoic acid (Andrews, 1998). At least NTera-2 can be induced to differentiate in distinct,
non-neural directions by hexamethylene bisacetamide (Andrews et al., 1990) and by bone
morphogenetic protein-7 (Andrews et al., 1994). The neurons differentiated from Tera-2 cells
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are functional cells that, when implanted to the brain of immunodeficient mice, differentiate and
adjust to the site of implantation (Kleppner et al., 1995; Miyazono et al., 1995; Miyazono et al.,
1996). In a recent study, NTera-2 derived neurons were implanted into the brain of rats with
unilateral striatal lesions, a model of Huntington’s disease. Compared to control animals, the
rats showed improvement in several aspects of their deficits suggesting that the transplanted
neurons could augment the function of damaged brain tissue (Hurlbert et al., 1999).
The mechanisms that regulate Tera-2 differentiation are poorly known. It has been shown that
different combinations of retinoic acid receptors and retinoid X receptors direct differentiation
into mesenchymal vs. neural cells (Moasser et al., 1994; Moasser et al., 1995; Spinella et al.,
1998). The expression of several growth factors and their receptors is altered during
differentiation. For example, the expression of epidermal growth factor receptor and its ligands
transforming growth factor  (TGF- and CRIPTO are downregulated during differentiation
(Dmitrovsky et al., 1990; Miller et al., 1990). Forced expression of TGF- in differentiated cells
restores their tumorigenic potential without affecting the expression of differentiation markers
(Baselga et al., 1993). This proposes a function for an EGFR dependent autocrine loop in
facilitating Tera-2 tumorigenicity. The presence of several other autocrine loops in
undifferentiated cells is probable.
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Melanocyte-nevus-melanoma
Origin and functions of pigment cells of the skin
Skin is the largest organ of the body. Among its many functions is to act as an active as well as
passive protective barrier against harmful factors of the environment. The basic structure of the
skin consists of two separate layers, the dermis and the epidermis. The dermis is composed of
connective tissue cells and nourishing blood vessels and capillaries along with several types of
other adnexal structures. The epidermis, separated from the dermis by a BM, is structurally
highly organized. Keratinocytes are the principal cell type of the epidermis and form the
cornified epithelium of the skin. Basal keratinocytes are proliferating cells that continuously
produce new cells to replace those shed from the outer surface. During differentiation the
keratinocytes lose their nuclei and ability to proliferate. When moved towards the surface of the
skin they transform into scale-like keratinous remnants that provide both chemical and physical
resistance. The thickness of the epidermis differs greatly in various parts of the body as a
function of the mechanical load it is exposed to.
Melanocytes are located within the basal layer of the epidermis. Unlike keratinocytes, they are
neural crest-derived cells that migrate to the epidermis as melanoblasts from the neural tube
during fetal development (see Goding and Fisher, 1997 for review). The main function of
melanocytes is to produce melanin pigment. One melanocyte transfers melanin particles,
melanosomes, to several surrounding keratinocytes through its dendrite-like extensions to form
a so-called epidermal melanin unit. The color of melanin dictates the color of the skin, while
there are no marked racial differences in the total amount of melanocytes. Melanin has an
important photoprotective function. It absorbs UV light and radicals generated by interaction of
UV photons with membrane lipids and other cellular chromophores (Pathak, 1995; Riley,
1997). In keratinocytes, melanin is distributed in protective caps around and on top of their
nuclei (Kobayashi et al., 1998). The significance of melanin can be clearly seen in amelanotic
conditions, such as vitiligo, where the demelanized areas of skin are extremely sensitive to
UV-induced sunburn (Gniadecka et al., 1996). Melanocytes respond to UV exposure by
enhanced melanin synthesis and transport. Tanning after sun exposure is the result of increased
amount of melanin in keratinocytes, not increased amount of melanocytes (Jimbow et al., 1993;
Gilchrest et al., 1998). Melanocytes are remarkably quiescent and dividing cells are rarely seen
in normal skin.
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The localization of melanocytes in the skin is tightly regulated. In cell culture, melanocytes
need either keratinocyte “feeder cells” or substancial growth factor stimulation to survive and
proliferate. Basal keratinocytes seem to support melanocytes also in vivo by producing several
paracrine growth factors. FGF-2 has been shown to be among these factors (Halaban et al.,
1987). Disturbance of the strict dependence of melanocytes on basal keratinocytes is a general
feature of melanocyte neoplasms.
Development and significance of nevi
Moles (benign nevus, common nevus, pigment nevus) are small (mostly less than 6 mm in
diameter), local areas of melanocyte proliferation. Moles owe their darkish color to melanin
pigment that is often found in large quantities inside nevus cells. Besides the proliferative
activity, nevus cells differ from normal melanocytes by their localization. While normal
melanocytes are only found intermingled in the basal layer of keratinocytes, nevus cells are
located to the vicinity of the BM (junctional nevus), deeper in the dermis (dermal nevus) or both
(compound nevus). Nevus cells seem to be less dependent on the supportive growth factors
secreted by keratinocytes.
There is no known function for common nevi. Not very much is known about the causative
factors leading to their development. A twin study revealed a strong correlation in the number of
nevi among monozygotic twins but not among dizygotic twins suggesting a role for inheritance
(Easton et al., 1991). Exposure to sun (ultraviolet radiation) in childhood has also been shown to
correlate with subsequent development of nevi in the exposed areas (Pavlotsky et al., 1997;
Kelly et al., 1994; Luther et al., 1996). It has been suggested that this is the consequence of
UV-induced subtle mutations. Other, possibly immune mediated mechanisms are suggested by
a study showing inverse association of nevi with sun exposure in immunosuppressed patients
(Bouwes Bavinck et al., 1996).
While nevus, as such, is a benign lesion, it seems to have a role in the development of more
malignant melanocyte neoplasms. Interestingly, the relatives of melanoma patients are at
elevated risk of developing dysplastic features in their nevi. The finding of dysplasia in a
patients nevus is an important risk factor for melanoma development. Dysplasia has also been
partly attributed to the same genetic markers as melanoma (see Greene, 1997 for review). The
risk of melanoma rises with the number of moles. In a large study the risk of melanoma in
subjects with more than 50 common nevi was 4.2 times higher compared to subjects with 0-4
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nevi while in subjects with more than 4 dysplastic nevi it was 23.7 times higher (Bataille et al.,
1996).
Malignant melanoma - clinical stages vs. molecular changes
Melanoma is one of the most common cancers in young adults. The frequency of melanoma has
increased by a factor of about 15 during the past 60 years (Glass and Hoover, 1989; Koh et al.,
1995). According to the Finnish Cancer Registry, the age-adjusted incidence of melanoma in
the Finnish male population has risen from 2.8 cases per 100.000 person-years in 1965-1969 to
7.8 cases in 1995-1997. In 1997 melanoma of the skin was the 12th most common primary
cancer diagnosed in the male and 8th most common in the female population (Finnish Cancer
Registry, 2000). Although melanoma mortality seems, at least in some populations, to have
reached a plateau (Iscovich et al., 1995; Giles et al., 1996), possibly because of enhanced early
detection, the incidence still seems to be growing (Armstrong and Kricker, 1994).
Both environmental and genetic factors predispose to the development of melanoma. UV
radiation is clearly the most important environmental factor. The incidence of melanoma is
highest in countries with subtropical or tropical climate and light-skinned population. In the
USA, the incidence among Afro-Americans is only 1/10 of that among caucasians (Parkin et al.,
1992). Melanomas have been experimentally induced by UV in certain animals and in human
skin grafted onto immunologically tolerant mice (see Satyamoorthy et al., 1999 for review).
Epidemiological studies have revealed that daily (for example occupational) substantial sun
exposure is less harmful than intense intermittent exposure (Bentham and Aase, 1996; Holman
et al., 1986; Nelemans et al., 1993). The risk is especially high in subjects with exposures that
induce sunburn. A history of five or more severe sunburns during adolescence causes doubling
of melanoma risk (Weinstock, 1996). In contrast to melanoma, other forms of skin cancer,
including basal and squamous cell carcinoma, are associated with cumulative sun exposure.
This discrepancy could be explained by the differential effects of UV on the apoptosis of
melanocytes and keratinocytes in vivo. After strong sun exposure, a large number of
“dyskeratotic” or apoptotic keratinocytes can be detected in the skin (Young, 1987). In contrast,
melanocytes seem to resist UV-induced apoptosis. This should be considered as rational since
melanocytes are needed to prepare the skin for subsequent exposures. Still, in pure cell cultures
in vitro, melanocytes undergo apoptosis after physiologic UV exposures (Zhai et al., 1996). The
greater in vivo resistance of melanocytes to apoptosis is partly explained by the fact that they are
far less likely to be actively cycling during UV-induced damage, and cells are most vulnerable
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to radiation effects during S phase of the cell cycle (DNA synthesis) (Danno and Horio, 1987).
Also, in response to UV radiation, keratinocytes have been shown to secrete growth factors,
such as NGF, that act as survival factors for melanocytes (Zhai et al., 1996).
Resistance to apoptosis after sunburn facilitates pigmentation of the skin and better protection
against further exposures. On the other hand, it can be speculated that melanocytes are
susceptible to accumulation of genetic lesions that are incompletely repaired by cellular DNA
repair mechanisms and should lead to deletion of the damaged cell.
Melanoma has long been known to occur familially (Cawley, 1952). The proportion of familial
cases is estimated to be 5-10%. Familial melanoma follows an autosomal dominant inheritance
pattern with penetrance of less than 80%. The tools for studying genes predisposing to a certain
disease have been developed during the past 20 years. The first successful linkage analyses with
melanoma-prone families showed moderately strong evidence for linkage between melanoma
and the short arm of chromosome 1 (Greene et al., 1983). Further analysis led to more accurate
localization to 1p36 (Bale et al., 1989; Goldstein et al., 1993). This finding could not be
duplicated by later studies, however, and a candidate gene in this region has not been identified.
More recently, a second site on chromosome 9p was identified on the basis of frequent
abnormalities in that area in melanoma cell lines. Multiple linkage analysis of subjects in 11
melanoma families further narrowed the locus to 9p21 (Cannon-Albright et al., 1992;
Cannon-Albright et al., 1994). Later, a candidate gene was identified from that area coding for a
Cdk inhibitor protein p16INK4a (Kamb et al., 1994) and germline mutations of this gene were
found in 33 of 36 patients with melanoma from 9 different families in the same study material
(Hussussian et al., 1994). Others have confirmed the finding of p16INK4a germline mutations
in about half of the families studied. Although a mutation in a CdkI is compelling as a
predisposing factor for melanoma
progression, it is clear that p16INK4a
mutations alone cannot explain familial
melanoma and further work is needed
to identify other hereditary factors.
Molecular abnormalities are frequently
found in sporadic melanoma, as well.
The most frequent currently known
gene alterations are listed in Table 3.
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Table 3
Gene abnormalities in sporadic melanoma
Gene Mechanisms Percent
p16 Absent or mutated gene 5-20
N-ras Overexpression or
mutation
5-15
p53 Mutated or absent gene 2-7
-catenin Overexpression or
mutation
15
PTEN Mutated 25
myc Overexpression 25
Other <1
PKC- Mutated
c-myb Mutated
CDK-4 Mutated
EWS-AFT-1 Translocation
NF-1 Mutated
Based on Meier et al., 1998.
Clinically and histopathologically
melanoma development and
progression can be divided into five
steps (Fig. 5; Meier et al.,1998).
Histological evidence for nevic origin
of melanoma can be found in about
35% of cases. It is possible that some
melanomas arise directly from
melanocytes but this is difficult to
show conclusively. The first step, from
melanocytes to nevus, has been
discussed above. The second step,
development of dysplasia in nevi is the
first one with some evidence of (so far
poorly specified) genetic changes
(Greene, 1997). The relative
independence of nevus cells from
keratinocyte control has been recently
explained by a gradual shift in
cadherin expression (Hsu et al., 1996).
E-cadherin has been proposed to
mediate the phenotypic control of
keratinocytes over melanocytes.
Keratinocytes and normal
melanocytes express almost
exclusively E-cadherin, while it’s
expression in nevus cells is
downregulated and N-cadherin
upregulated. Melanoma cells express
almost exclusively N-cadherin, which is thought to facilitate interactions of melanoma cells
with N-cadherin-expressing fibroblasts and endothelial cells.
The shift from dysplastic nevus to in situ radially spreading melanoma is gradual (Meier et al.,
1998). Although the former is considered to be premalignant and the latter malignant, there is
little difference in the cells’ behavior for example in cell culture. In contrast, the shift from
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Figure 5. Melanoma development. Melanoma development can
be divided into steps. According to the present view, most but not
all melanomas are associated to benign nevi. The expression of
certain autocrine growth factors (e.g. FGF-2) is upregulated in
nevus cells, possibly causing the resistance to TGF--induced
apoptosis in collagen gel and dermis. Nevus cells have recently
been shown also to express a member of the family of inhibitor of
apoptosis proteins (IAP) called survivin (Grossman et al., 1999).
The cadherin profile of nevus cells is different from normal
melanocytes, which is thought to enable growth independently of
keratinocyte support. Dysplasia, the first sign of malignant
progression in nevus cells, is thought to be the result of as yet
undefined genetic changes. Radial growth phase (RGP, in situ)
melanoma cells are poorly tumorigenic and not capable of
metastasis. The differences between dysplastic and RGP
melanoma cells are often minor. On the contrary, progression to
vertical growth phase (VGP) seems to be associated with further
genetic changes and upregulation of several growth factors. The
forced expression of 3 integrin alone permits conversion from
RGP to VGP melanoma in vitro (Hsu et al., 1998). Invasive
melanoma cells also express several matrix metalloproteinases
(MMPs) and their tissue inhibitors (TIMPs) (Hoffmann et al.,
2000; Airola et al., 1999). Aggressively growing, metastatic
melanoma cells produce a multitude of growth factor receptors
and ligands and are evidently independent of support from
neighboring cells. Adapted from Meier et al., 1998.
radial growth phase to vertically growing melanoma is critical and probably preceded by further
genetic changes since the growth characteristics of these cells are quite different (Satyamoorthy
et al., 1997). Cells from vertically growing melanoma are almost independent of exogenous
growth factor stimulation, they can grow anchorage-independently in soft agar and cause
tumors in nude mice. Rather surprisingly, vertical growth, invasiveness and tumorigenicity
could be experimentally induced in radially growing melanoma cells by forced expression of 3
integrin (Hsu et al., 1998). The genetic instability of melanoma cells favors selection of poorly
differentiated, highly invasive and metastatic phenotypes with very modest growth
requirements. Metastatic melanoma cells express several growth factors and cytokines with
both autocrine and paracrine stimulatory functions (Meier et al., 1998 ).
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AIMS OF THE PRESENT STUDY
Research in cell biology is for the most part based on studies utilizing cultured cells. Although
the actual environment of cells in vivo is a three-dimensional network, they are still cultured and
observed in two-dimensional cultures, where they are surrounded by a thin layer of matrix
produced by the cells themselves. The current work was undertaken to study the behavior of
cells in a controllable, three-dimensional matrix. The goals were:
1) To develop a controllable, three-dimensional cell culture system where the cells can be
easily observed in the presence of even or graded concentrations of various growth factors and
chemicals.
2) To use this system to study the effects of growth factors on migration and phenotype of
cells undergoing differentiation.
3) To explore differences in the behavior of normal melanocytes, nevus cells, and
melanoma cells grown in a three-dimensional environment, which bears some resemblance
with the dermal compartment of the skin.
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MATERIALS AND METHODS
Cell lines
Cell culture (I-V)
Tera-2 cells were maintained in Eagle’s minimal essential medium (MEM) supplemented with
10% fetal calf serum (FCS). Differentiation was induced by plating the cells on gelatin-coated
tissue culture plates (2 x 103 cells/cm2) and adding 20 M retinoic acid (RA) to the medium the
following day. The cells were typically used after at least 10-d differentiation.
BCE cells were isolated from adrenal cortex according to published procedures (Folkman et al.,
1979). Initial isolates were grown in MEM alpha medium (Gibco/BRL) containing 10%
newborn calf serum (NCS) and endothelial cell growth supplement (Sigma). After cloning, the
cells were grown in the absence of growth supplement. The clones stained positively for factor
VIII-related antigen (-FVIII-Ag, Dako).
U-251 MG cells were maintained in MEM + 10% NCS. In co-culture experiments the cells were
-irradiated (6000 rad) to prevent cell proliferation and allowed to recover for 1 d before use.
Human skin melanocyte cultures were established from normal adult human skin. Most of the
dermis was removed by a scalpel in visual control. The remaining layers were treated with
dispase (Collaborative Biomedical Products) for 20 min to enzymatically separate the
epidermis. The epidermis was then treated with trypsin-EDTA for 15-30 min. Detached cells
were cultivated in a selective F-12 medium (Gibco/BRL) containing 10% FCS, 1 g/ml cholera
toxin (CT, Sigma), 10 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma), and 3 ng/ml
human recombinant FGF-2 (a gift from Dr. Andreas Sommer). In 50% confluence the plates
were treated with Geneticin (100 ug/ml, Sigma) for 7-10 d to kill remaining contaminant cells.
Nevus cell cultures were established from excised intradermal or compound-type nevi. The
epidermis was mechanically removed to the depth of the dermal papillae. The superficial dermis
was mechanically minced and treated with collagenase (type IX, Sigma) to produce a cell
suspension. The cells were plated and treated as described above for melanocytes.
Both melanocyte and nevus cell cultures stained 100% positive for S-100 (antibodies from
Dako) and GD3 ganglioside (antibodies from Biogenesis). The cells were used between
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Cell line Description Source Used in
Tera-2 (clone 13) human embryonic carcinoma Dr. C.F. Graham I, II
BCE bovine capillary endothelial bovine adrenal cortex I
U-251 MG human glioma ATCC I
Melanocytes (Mela) human epidermal melanocytes human skin III, IV, V
Nevus cells human dermal nevus cells human dermal or junctional
pigment cell nevus
III, IV
ML793 (WML793) human VGP melanoma Wistar Institute IV
G-361 human metastat ic melanoma ATCC IV
Mv1Lu mink lung epithelial cells ATCC IV
passages 4-15. Before each experiment the cells were kept in F-12 + 10% FCS without
supplements for 24-48 h.
ML793 and G-361 melanoma cell lines were cultured in RPMI-1640 medium containing 10%
FBS.
Mv1Lu cells were cultured in Dulbecco’s modified Eagle’s medium containing 10% FBS.
Construction of three-dimensional collagen lattices (I-V)
The collagen gels were prepared by mixing type I collagen stock solution (3-5 mg/ml) with an
equal volume of 2X medium. The gel was allowed to polymerize for 30 min at 37°C (5% CO2
atmosphere). Cells were seeded on top of this layer. They attached tightly in 30 minutes. A
second layer of collagen was cast and solidified. Complete culture medium was added on top of
the collagen sandwich to provide the cells with sufficient nutrients during prolonged
experiments.
When desired, growth factors, cytokines and antibodies were either included in collagen layers
or added to the medium on top from which most substances readily spread to the collagen layers
by passive diffusion.
For migration assays (I), the cells were allowed to attach inside a plastic ring inserted on top of
the first collagen layer. After 30 min the ring was removed and unattached cells were rinsed
away. A second layer of collagen was cast as usual. The culture medium layer was solidified by
0.75% low-melting-point agarose (FMC Bioproducts). To establish a growth factor gradient, a
well (diameter 3 mm) was punched through all the layers on both sides of the cell spot (distance
4 mm), and the growth factor was introduced into one of the wells. The second well served as a
vehicle control. Photomicrographs of the migrating cells were taken through an Olympus CK-2
inverted microscope.
Preparation of ECM isolates (I)
BCE and glioma cells were maintained in the presence of 5% Dextran T40 as confluent cultures
for 5-7 d. The matrices were prepared by extracting cells with 0.5% Triton X-100 and 20 mM
ammonium hydroxide in PBS (Ishai-Michaeli et al., 1990). The resulting matrix was rinsed
extensively with the extraction buffer and PBS.
HSPGs were purified from the matrix preparations by dissolving the matrix in 4 M guanidine in
50 mM Na-acetate, pH 6.0. The buffer was changed to 8 M urea in 50 mM Na-acetate, pH 6.0,
using a G-10 Sepharose salt exchange column (Pharmacia) and the proteoglycans were bound to
DEAE-dextran (DE-52, Whatman Biosystems). The HSPGs were eluted between 0.25 and 0.5
M NaCl in 0.1 M PO4, pH 7.4 (Yanagishita et al., 1987; Saksela et al., 1988).
Northern blotting (I-III)
Poly A+ mRNA was isolated according to published procedures (Glisin et al., 1974; Schwab et
al., 1983). Equal amounts, determined by OD260, were electrophoresed on 0.8% agarose gels
and blotted onto nylon membranes (Pall).
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The cDNA fragments used as probes were labeled with [-32P]-dCTP (Amersham) using a
random priming kit (Pharmacia Biotech). The probes included: FGF-2 (I-III) (Sommer et al.,
1987), FGF-4 (I-II) (Delli-Bovi et al., 1987), Rb (II) (provided by Dr. Yuen Kai Fung), FGFR-1
and FGFR-2 (III) (Dionne et al., 1990), and FGFR-3 and FGFR-4 (III) (Partanen et al., 1991).
Signal quantitation was accomplished by densitometric scanning of exposed autoradiography
film (I-II) or by a bio-imaging analyzer (Fuji BAS-1500; III).
Immunohistochemistry (I)
The cells and collagen lattices were fixed in 3.5% PFA at 4°C for 1 h. After washing with PBS
the specimens were permeabilized with 0.5% Triton X-100, rewashed, and exposed to primary
antibodies followed by FITC-conjugated secondary antibodies for 4-6 h each. The stained cells
were photographed with an Olympus BH-2 fluorescence microscope.
Western blotting (II, III, IV)
FGF-2 sample preparation
Cells were lyzed with 1% Triton X-100/2 M NaCl in PBS in the presence of proteinase
inhibitors (aprotinin, AEBSF, Pepstatin A). Equal amounts of protein were diluted 1:10 with
distilled, deionized water and incubated on a mixer for several h with Heparin-Sepharose
particles (Pharmacia Biotech). The heparin-bound FGF-2 was released by either eluting with 2
M NaCl followed by TCA precipitation (II) or by resuspending the particles in reducing
Laemmli sample buffer and boiling (III).
TGF- sample preparation
Cells were lyzed with 0.5% NP-40 in 120 mM NaCl, 25 mM Tris, pH 8, in the presence of
proteinase inhibitors (aprotinin, AEBSF, Pepstatin A). Equal amounts of protein were mixed
with 2X reducing Laemmli sample buffer and boiled.
Conditioned media were collected and concentrated 10X with Centricon 10 (Amicon). A 50-l
aliquot was mixed with 2X reducing Laemmli sample buffer.
Electrophoresis and antigen detection
The samples were electrophoresed in 12% SDS-PAGE gel followed by electroblotting onto a
nitrocellulose filter (Schleicher & Schuell). After primary antibodies, biotinylated
species-specific secondary antibodies followed by streptavidin-HRP were used. HRP was
visualized with enhanced chemiluminescence (Amersham). Monoclonal antibodies against
neurofilament polypeptides (I-II) were kindly provided by Dr. Ismo Virtanen (Virtanen et al.,
1985). FGF-2 antibodies (I-III) were produced in rabbits as described in I. Rabbit polyclonal
TGF-1 antibodies (IV) were a kind gift from Dr. Jorma Keski-Oja (Taipale et al., 1992).
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Staining of apoptotic cells (II-V)
Hoechst staining
The collagen gel cultures were fixed with 3-3.5% paraformaldehyde for 30 min at room
temperature or for 12 h in +4EC. The gels were then exposed to 1 g/ml bisbenzimide (Hoechst
33342; Sigma) for 10-30 min. After thorough rinsing with PBS, the gels were inspected and
photographed with a fluorescence microscope under UV illumination. Condensed and
fragmented nuclei were counted as apoptotic.
TUNEL staining
Apoptotic DNA cleavage was detected in situ by a modification of the original TUNEL method
(Gavrieli et al., 1992). The collagen gels were either fixed with 3.7% formaldehyde in PBS for
at least 16 h or fixed with 3.5% paraformaldehyde for 12 h and treated with 2% H2O2 for 20 min.
They were covered with a labeling mixture containing dATP, terminal deoxinucleotidyl
transferase (Promega) and either digoxigenin- (Boehringer Mannheim) or fluorescein-labeled
(New England Nucleotides) dUTP. Digoxigenin-labeled nucleotides were detected by
anti-digoxigenin-POD conjugate (Boehringer Mannheim) and DAB substrate.
Fluorescein-labeled nucleotides were detected using a fluorescence microscope equipped with
the appropriate filters.
DNA fragmentation analysis (II, III)
To analyze low-molecular-weight fragments of genomic DNA the cells were lyzed with 150
mM NaCl, 25 mM EDTA, 0.2% SDS. The lysate was treated with proteinase K (Boehringer
Mannheim), extracted with phenol-chloroform and treated with RNAse A (Sigma). DNA was
precipitated with ethanol and loaded onto a 1.8% agarose gel with markers. After
electrophoresis DNA was visualized by staining with ethidium bromide.
To analyze high-molecular-weight fragments the cells were lyzed with 1% SDS and loaded onto
a 1% agarose gel. The electrophoresis was performed in a clamped homogenous field apparatus
(CHEF-DR-II; Bio-Rad). The gel was stained with ethidium bromide.
Cell proliferation assays (III, IV)
Cell proliferation was measured either using CellTiter 96 AQ kit (Promega) according to
manufacturers instructions (III) or by 5-BrdU incorporation and immunostaining (IV). In latter,
the cells were seeded on glass coverslips and grown overnight. The factors of interest were
added to the growth medium for the following 48 h. 250 M 5-BrdU (Sigma) was added 4 h
(melanoma cells) or 48 h (melanocytes) before the end of the incubation. The cells were fixed
with ice-cold methanol and permeabilized by a brief treatment with 1.5 N HCl. The cells were
stained with monoclonal antibodies to BrdU (Amersham) and a secondary,
rhodamine-conjugated antibody (Jackson). The nuclei were briefly stained with Hoechst as
above.
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Mv1Lu growth inhibition test (IV)
The growth-inhibitory activity secreted by cultured cells was analyzed in Mv1Lu cell assay
(Laiho et al., 1990). The cells were plated on 24-well plates 24 h prior to the experiment.
Conditioned media were collected from the experimental cultures and either used as such or
heat-treated (90°C, 1 min) to activate latent forms of TGF-. Mv1Lu medium was replaced by
the conditioned medium of interest. After 18 h 5-BrdU was added for the last 2 h. The cells were
fixed with 3.5% paraformaldehyde, permeabilized with 0.5% NP-40 and 1.5 N HCl, and the
incorporation of 5-BrdU was measured essentially as described above. The growth inhibitory
activity was identified as TGF- by using neutralizing chicken egg yolk anti-TGF-1 IgY.
Analysis of intracellular ROS level (V)
The oxidative stress of cultured cells was analyzed using fluorescent, oxidation sensitive
markers, dichlorofluorescin diacetate (DCFH-DA; Sigma) and dihydroethidium (DHE;
Molecular Probes). The markers were added to the culture medium for the last 4 h of incubation
with desired supplements. Cells were either trypsinized from plates or released from collagen
gel by collagenase treatment. Intracellular production of highly fuorescent oxidation products
dichlorofluorescein (DCF) and ethidium was measured by a FACS analysator using FL1 and
FL2 filter sets, respectively. 10.000 events were recorded per sample. Cell debris was gated out
based on forward scatter.
Analysis of Bcl-2 protein expression by FACS (V)
Bcl-2 expression was analyzed by FACS analysis. Cells were either trypsinized from plates or
released from collagen gel by collagenase treatment. After washing the cells were fixed with 1%
PFA at room temperature for 5 min, centrifuged and permeabilized with ice-cold 70% methanol
for 15 min. The cells were resuspended in PBS + 1% serum and incubated with monoclonal
anti-Bcl-2 (Santa Cruz Biotechnology) for 30 min in +4°C. The secondary antibody used was
species specific FITC-conjugated Fab. Thorough washing was followed by FACS analysis of
the samples using FL1 filter set. 10.000 events were recorded per sample. Cell debris was gated
out based on forward scatter.
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RESULTS AND DISCUSSION
A model to study the migration and phenotype of cells in vitro in a
three-dimensional lattice (I-V)
The three-dimensional cell culture model used throughout this thesis was originally developed
in our laboratory to study angiogenesis in a true in vitro assay as an attempt to avoid some of the
problems arising in the conventional cell culture system. The angiogenic potential of growth
factors and other substances can also be determined by often laborous in vivo assays, for
example by applying biologically active materials on the chorioallantoid membrane of a
chicken embryo or in the cornea of a rabbit. Several extracellular matrix preparations were
tested during development of the assay (Alanko and Saksela, unpublished results). Collagen
gels had previously been widely used mainly to study fibroblasts in a three-dimensional
environment (Elsdale and Bard, 1972; Schor, 1980; Tomasek et al., 1982; Bell et al., 1979;
Mauch et al., 1988) and collagen was commercially available in large quantities. Type I
collagen gel also had the benefit of being almost completely transparent. It allowed diffusion of
growth factors and development of a concentration gradient. The model has since been used in
several studies to quantitate the potential of growth factor preparations to trigger cell migration
and/or angiogenesis (Joukov et al., 1996; Joukov et al., 1997; Joukov et al., 1998).
Type I collagen gel is a protein matrix that lacks several components of natural intersitial
connective tissue. It still clearly differs from soft agar and related growth environments that
prohibit cell attachment. Firstly, type I collagen is a naturally occurring glycoprotein polymer
and although it is not the sole constituent of any ECM, it is one of the major components of
some. Secondly, during gelling collagen renatures and takes on a conformation that resembles
naturally occurring collagen networks. In contrast, denatured collagen, or gelatin, that has
widely been used to coat cell culture surfaces, forms a thin film of mostly denatured collagen.
Thirdly, collagen gel favors cell attachment. All cell types tested attach to collagen quickly.
After 30 minutes practically all viable cells have attached. Malignant but also several benign,
terminally differentiated cell types remain attached and viable for very long periods of time.
More advanced three-dimensional cell culture environments have been designed lately. For
example, the structure of skin can be reconstructed in vitro by layering keratinocyte-melanocyte
cocultures (epidermis) on top of collagen embedded fibroblasts (dermis) (Chen et al., 1995;
Meier et al., 2000; Satyamoorthy et al., 1999). In this kind of organotypic cultures, the cells
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appear surprisingly similar to their in vivo counterparts. On the other hand, the presence of
several cell types hampers the use of many biochemical methods to analyze one single
subpopulation such as the melanocytes.
Differentiation of Tera-2 cells is accompanied by development of growth factor
dependency
Undifferentiated Tera-2 cells respond to FGF-2 by enhanced proteolysis and migration
towards higher concentration (I)
Tera-2 cells represent malignant neural crest-derived cells capable of differentiation to neurons
in response to all-trans retinoic acid (RA) treatment (Thompson et al., 1984). Undifferentiated
Tera-2 cells proliferate rapidly in cell culture and are tumorigenic in nude mice. FGF-2 does not
markedly affect their proliferation rate but it induces a change in their phenotype towards
proteolytically active, migratory cells (Tienari et al., 1991).
To study the migration of Tera-2 cells in response to various growth factors the cells were
grown between two layers of collagen gel in a sharply demarcated area in the middle of a cell
culture dish and the growth factors were applied to the gel outside this area to form a
concentration gradient (I).
Undifferentiated Tera-2 cells grew in collagen as tight cell clusters. A gradient of FGF-2
induced directional migration towards higher concentrations, whereas addition of FGF-2 to the
gel caused scattering of the cells through random migration. Several other growth factors were
tested for their ability to induce migration of Tera-2 cells. Only FGF-1 and, to a somewhat lesser
extent, EGF were effective (I).
The ability of FGF-2 to induce migration of Tera-2 cells can be partly explained by their
enhanced proteolysis (Tienari et al., 1991). It is also possible that FGF-2 substitutes a paracrine,
matrix-bound growth factor required by the cells, such as FGF-4 or FGF-2 itself, and thus
allows growth independently of contacts to matrix and the neighboring cells.
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Differentiation of Tera-2 cells inhibits their migration and renders them susceptible to
apoptosis in three-dimensional collagen gel (I, II)
Retinoic acid induces neuronal differentiation of Tera-2 cells. Differentiation causes a dramatic
change in the appearance of Tera-2 cells. They gradually start expressing neuronal marker
molecules and develop neuron-like extensions. Differentiated cells express specific proteinase
inhibitors in their pericellular structures. FGF-2 enhances their overall proteolytic potential
only slightly (Tienari et al., 1991).
When the differentiated cells were embedded in collagen gel the cells rapidly started to die. Cell
death was effectively counteracted by addition of FGF-2. A gradient of growth factor did not
induce migration of the differentiated cells but they survived in the areas with sufficiently high
concentration of FGF-2. Of the other growth factors tested, only FGF-1 and FGF-4 (II) could
induce Tera-2 survival. EGF, that had an effect on the migration of undifferentiated Tera-2
cells, could not promote the survival of differentiated cells (I).
As a control experiment, the differentiated cells were first let to attach onto the surface of a plain
culture dish and then covered with collagen gel. The cells did not die when in contact with the
bottom of the dish, which implies that their death is not mediated by soluble factors possibly
contaminating the collagen preparation.
After release in vitro and probably also in vivo, FGF-2 is quickly bound to HSPGs of the ECM
(Saksela et al., 1988; Flaumenhaft and Rifkin, 1992). To find out whether Tera-2 cells could
benefit from matrix bound FGF-2, the HSPG rich matrix of glioma cells and bovine capillary
endothelial cells was isolated. Both cell types synthesize FGF-2. When the cells were induced to
differentiate inside the collagen gel, they remained alive only in areas of the isolated matrix
preparations. Also addition of purified HSPG from glioma or capillary endothelial cells known
to contain FGF-2 mediated survival of the cells. Their survival was inhibited by neutralizing
FGF-2 antibodies (I).
Close observation of the death of Tera-2 cells in collagen gel revealed morphological
resemblance to apoptotic cell death. The cells first attached to collagen and sent several
dendrite-like extensions to their environment. Within a few days the cells lost these extensions
and rounded up with extensive blebbing of the plasma membrane. A DNA stain (Hoechst
33342) revealed chromatin condensation and, later, fragmentation of the nucleus. To confirm
the apoptotic nature of cell death, the cells were stained by the TUNEL method. TUNEL
staining revealed DNA strand breaks in 75-80% of the cells after 4 days in collagen gel.
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Addition of FGF-2 (20 ng/ml) slowed down the rate of apoptosis by about 50%. Although
FGF-4 also had some protective effect, it was less potent than FGF-2 (II).
Tera-2 cells lose the expression of endogenous FGF-2 during differentiation in
three-dimensional collagen gel
It is known from previous work by others (Miller et al., 1990) that the expression of several
growth factors changes during differentiation of Tera-2 cells by RA. To study whether a change
in autocrine or paracrine FGF-2 stimulation could explain the death of differentiated cells in
collagen, their FGF-2 expression was investigated using Western blotting enhanced by a
heparin-Sepharose affinity based concentration step (see Materials and methods). It was found
that in aconventional cell culture RA treatment alone does not cause marked downregulation of
FGF-2 expression. However, the regulation of FGF-2 expression was different in collagen gel.
Complete disappearance of endogenous FGF-2 protein was seen in three-dimensional collagen
following RA-induced differentiation. The downregulation of FGF-2 protein expression took
place gradually 48-72 h after transfer of the cells into collagen (II).
Northern blotting analysis of FGF-2 mRNA expression was performed to confirm the results
obtained by Western blotting. In accordance to protein determinations, the RA treated cells
cultured in collagen gel for 2 days almost completely lost the expression of FGF-2 mRNA (II).
The mRNA expression of another member of the FGF family known to be expressed by Tera-2
cells, namely FGF-4 (K-FGF), was also analyzed. The results were similar to FGF-2 with the
exception that RA seems to efficiently downregulate FGF-4 mRNA expression also in the
absence of collagen (II).
FGF-2 is an important neurotrophic factor (Amaya et al., 1991; Anderson, 1993; Morrison et al.,
1986; Slack et al., 1987; Westermann et al., 1990). Some FGFs have been demonstrated to have
a role during development and differentiation of the nervous network. FGF-2 is also expressed
in the mature brain. It is known to have a supportive role and be involved in regeneration after
injury (Kuzis et al., 1999; Pataky et al., 2000). Development of FGF dependency in Tera-2 cells
following RA induced differentiation has similarities to the events taking place in vivo during
differentiation and migration of neural progenitor cells. A gradient of neurotrophic factors is
thought to guide the migration. Most of the cells are misguided or only serve a temporary role
during the process of development. These cells probably undergo apoptosis triggered either by
loss of trophic factors or by some other defined cellular program (Bronner-Fraser, 1993). The
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cells that reach areas where the survival factors are available remain alive and ultimately form
the functioning central and peripheral nervous systems.
The apoptosis of differentiated Tera-2 cells in collagen seems to be triggered by loss of a vital
autocrine growth factor loop. The mechanisms that mediate different regulation of FGF-2
expression in collagen compared to conventional two-dimensional culture, are not fully known.
Alterations in the surrounding ECM are known to have profound effects on cell phenotype and
growth, and even to induce apoptosis (Ruoslahti and Reed, 1994). Adhesion to a substrate
creates signals that are mediated inside the cell by adhesion receptors like the integrins. The
finding that apoptosis is not induced in cells that have adhered to a conventional cell culture
plate even when they are covered with a layer of collagen gel indicates that the contact to
collagen is not deleterious to the cells as such. Rather, a collagen environment might not
facilitate stimulation of, as yet unidentified, necessary integrins. One of the functions of those
vital integrins might be the regulation of FGF-2 expression.
Melanocytes are susceptible to apoptosis in collagen gel in the absence of
FGF-2 stimulation
Unstimulated melanocytes undergo apoptosis in collagen gel
Normal melanocytes form an almost nonproliferating cell population in the basal epidermis.
They are dependent on supportive factors produced by the surrounding keratinocytes (Halaban,
1996). In cell culture melanocytes require strong growth factor stimulation to proliferate. When
left without stimulation they stop dividing and only slowly start to deteriorate after several days
in culture (III). The localization of melanocytes is strictly regulated and normal melanocytes
are never found in the dermis. On the contrary, nevus cells and malignant melanocytes have the
ability to invade the dermis. To observe the behavior of melanocytes in an environment that
mimicks the dermal extracellular matrix more closely than the conventional cell cultures, they
were cultured in collagen gel. Melanocytes have been reported to express integrins that mediate
attachment to type I collagen, namely 21 and 31 (Hara et al., 1994).
When normal melanocytes were seeded in three-dimensional collagen they quickly attached
and spread their dendrite-like extensions into the gel. In the absence of added growth factors, the
first cells started showing signs of deterioration in a few hours after seeding and then gradually
lost their extensions and rounded up. In 3 days about 35% of the cells showed morphological
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signs of apoptosis. Hoechst staining revealed variable degrees of chromatin condensation and
nuclear fragmentation. TUNEL staining revealed DNA breaks in the same cells confirming the
apoptotic nature of cell death. Addition of laminin and/or fibronectin to the collagen gel did not
affect the cell death rate (III).
The results suggest that the extracellular matrix has an important role in the regulation of
melanocyte survival. The mechanism that causes apoptotic death of cells in collagen in vitro has
the potential of serving as an effective mechanism to restrict survival of melanocytes in the
dermis in vivo and facilitate their strict localization into the epidermal compartment.
Fibroblast growth factor-2 acts as a survival factor for melanocytes in collagen gel
When melanocytes were seeded into three-dimensional collagen and cultured in the presence of
FGF-2, the cells attached like control cells. They, however, showed considerably less signs of
apoptotic death and most of the cells survived for extensive periods of time. Hoechst and
TUNEL staining revealed few apoptotic cells after 5 days in collagen (III).
FGF-2 is a natural growth factor for melanocytes. It is one of the factors involved in paracrine
stimulation of melanocytes by basal keratinocytes (Halaban et al., 1988). It has also been
previously shown that although normal melanocytes express very little or no FGF-2, malignant
melanocytes and nevus cells very commonly produce high levels of endogenous FGF-2 (Scott
et al., 1991). The same cell types are also capable of living without support from keratinocytes
in the dermis.
Nevus cells survive in three-dimensional collagen without exogenous FGF-2
Nevus cells are phenotypically benign melanocytic cells that have distinct growth
characteristics in vivo. Unlike normal melanocytes that grow intermingled between
keratinocytes and seem to be territorial in the sense that they are never found in clusters, nevus
cells form nests in the epidermis and dermis. Mitotic activity is more often detected among
nevus cells than among normal melanocytes in situ (Rieger et al., 1993).
Nevus cell cultures were established from the dermal part of human compound or dermal nevi.
When grown in collagen gel, nevus cells survived without exogenous supportive growth factors
(III). The FGF-2 expression of normal melanocytes and nevus cells was analyzed by Northern
and Western blotting techniques. The expression level in melanocytes was very low. Nevus
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cells showed modest expression of FGF-2 on mRNA level but relatively high amounts of FGF-2
protein. The expression of FGFR-1 was also confirmed by mRNA analysis in both cell types
(III).
To demonstrate the possible autocrine or paracrine role for FGF-2 in nevus cells, they were
cultured in three-dimensional collagen gel in the presence of protamine, a rather unspecific but
effective inhibitor of FGF-2 receptor interactions. Protamine treated nevus cells became
susceptible to apoptosis in collagen. The effect of protamine could be overcome by high
concentrations of exogenous FGF-2. Also, protamine as equivalent or higher concentrations
was not toxic to nevus cells or melanocytes in conventional cell culture.
Endogenous expression of FGF-2 has been connected to increased cell survival in several cell
types, both benign and malignant (see Szebenyi and Fallon, 1999 for review). In the case of
nevus cells it seems to have the potential to enable their growth outside the epidermis, without
contact to keratinocytes.
Transforming growth factor  and fibroblast growth factor-2 have opposite
effects on melanocyte apoptosis in collagen gel
Transforming growth factor  inhibits the growth of melanocytes and nevus cells
Transforming growth factor s (TGF) comprise a family of principally inhibitory growth
factors. The roles of TGF differ in various parts of the skin. In the dermis it enhances matrix
deposition and has an important role during wound healing (Roberts et al., 1986; Massagué,
1990). It acts as a growth inhibitor for epidermal keratinocytes both in vivo and in vitro. Lack of
TGF receptor activation in the skin of transgenic mice has been shown to lead to increased
incidence of carcinomas (Wang et al., 1997; Wang et al., 1999). TGF has been shown to
induce apoptosis in several cell types (Yanagihara and Tsumuraya, 1992; Moulton, 1994;
Rotello et al., 1991; Oberhammer et al., 1992; Fabregat et al., 1996; Fukuda et al., 1993).
To investigate the effect of TGF- on melanocyte growth and apoptosis the cells were cultured
in conventional cell culture in the presence of TGF1. Unstimulated melanocytes are
quiescent as such. TGF had no stimulatory effect on them, nor did it induce accelerated cell
death. When TGF1 was introduced to melanocytes that had been stimulated to proliferate by
strong PKC and cAMP activators, it effectively inhibited their replication again without
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affecting the rate of cell death (IV). These results were in line with previous studies that have
suggested a role for TGF as an inhibitor of melanocyte growth (Rodeck et al., 1994).
Transforming growth factor  accelerates the apoptosis of melanocytes in collagen
Melanocytes that are grown in three-dimensional collagen gradually undergo apoptosis. When
TGF1 was added to collagen cultures, it caused significant acceleration of apoptosis. In 2
days about 90% of melanocytes had died. TGF effect could be effectively reversed by
specific TGF1 antibodies. The effect was dose-dependent and detectable already at
physiological concentrations (IV). FGF-2, that promotes the survival of melanocytes in
collagen gel, counteracted also the TGF- effect. FGF-2 was not able to totally prevent
apoptosis but the proportion of apoptotic cells after 2 days was lowered by more than 50%.
As a control, the effect of two growth inhibitory factors with apoptotic potential, namely TNF-
and IFN- was tested. These factors were unable to affect the rate of melanocyte apoptosis in
collagen (IV).
Endogenous TGF produced by melanocytes is involved in their apoptosis in collagen
Apoptosis in the presence of exogenous TGF1 takes place faster but is otherwise
morphologically very similar to the “background” apoptosis of normal melanocytes in collagen
lacking proper stimulation by FGF-2 (III, IV). To explore the possibility that endogenously
expressed TGF is involved in the apoptosis, neutralizing TGF1 antibodies were added to
collagen gel. The apoptotic rate of normal melanocytes decreased in the presence of antibodies.
However, the maximal inhibition of apoptosis did not exceed 50% (IV). The limited effect
could result from relatively slow diffusion of antibody molecules in collagen that hampers their
ability to neutralize newly synthesized and activated TGF1. It is also possible that other
TGF subtypes are present and the subtype 1-specific antibody does not recognize them.
To investigate whether TGF is present in the collagen cultures as an impurity or whether it is
endogenously produced by melanocytes, Western blot analysis of the collagen preparation, cell
lysates and conditioned media was performed. A relatively high expression of TGF1 protein
was detected in melanocyte lysates. Ten times concentrated conditioned medium and the
undiluted collagen preparation were completely negative (IV).
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Although the sensitivity of the Western blotting assay allowed detection of 0.1 ng recombinant
TGF1 per lane, the theoretically lowest detectable concentration in conditioned medium was
about 0.2 ng/ml. A mink lung epithelial cell (Mv1Lu) growth inhibition assay was used for
increased sensitivity (see Materials and methods). The serum free conditioned medium of
melanocytes was shown to contain growth inhibitory activity that was only detectable after heat
treatment of the samples. The activity was partly inhibited by TGF-1 antibodies, which
identifies it as latent TGF-1 (IV). TGF- is secreted from most cells in latent form. The partial
inhibition suggests the presence of other subtypes in the conditioned media besides TGF1.
As a strong inhibitor of melanocyte growth, TGF probably has regulatory functions in the
skin. It has been shown to be present in the dermis and epidermis (Dagnino et al., 1993; Taipale
et al., 1994; Karonen et al., 1997, Raghunath et al., 1998). These results point to an endogenous
suicide mechanism that melanocytes carry with them and that gets activated whenever the cells
end up outside their normal environment.
Nevus cells and melanoma cells are insensitive to the pro-apoptotic effect of TGF
Nevus cells and vertically growing melanoma cells have broken the natural barrier formed by
the BM and can be found on its dermal side. As mentioned earlier, mitotic activity can be
detected in nevi, although less commonly than in melanomas. In aggreement with that, unlike
normal melanocytes, nevus cells proliferated in cell culture even in the absence of strong
stimulants and growth factors but were further stimulated by them. In either case, TGF1
effectively inhibited their growth. However, TGF1 added to the cultures did not affect the
survival of nevus cells in three-dimensional collagen gel. Nevus cell lysates and conditioned
media were investigated for TGF1-like activity by Western blotting and Mv1Lu growth
inhibition assay, respectively. The observed levels were comparable to those detected in normal
melanocytes (IV).
Previous studies (Filmus and Kerbel, 1993; Krasagakis et al., 1999; Rodeck et al., 1994) have
suggested that melanomas gain resistance to TGF effects during malignant progression.
TGF did not inhibit the rapid proliferation of the two melanoma cell lines tested. When
melanoma cells were cultured in three-dimensional collagen, their apoptosis was not increased
and addition of TGF was ineffective in inducing apoptosis. Mv1Lu growth inhibition assay
indicated that melanoma cells secrete large amounts of latent TGF into their medium (IV).
This has also been previously described in the literature. Melanoma cell secreted TGF has
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been suggested to have a role in regulating the synthesis of connective tissue stroma of the
tumor. Also, TGF has immunosuppressive effects that could be very beneficial in protecting
malignant cells from the host immune system (Ruffini et al., 1993).
The evidence presented above confirms that FGF-2 is a strong supportive factor for
melanocytes. It promotes their survival in collagen that is an unphysiological environment for
normal melanocytes. In vivo, melanocytes need contact to keratinocytes and the BM. By an
unknown mechanism, FGF-2 can overcome this requirement. Nevus cells, which are stimulated
by an autocrine FGF-2 loop, are able to grow in the dermis without keratinocyte and BM
contacts. TGF- is inhibitory to melanocyte and nevus cell growth. Endogenous TGF- seems
to mediate the apoptosis of melanocytes in collagen. Also nevus cells and melanoma cells
produce and probably activate TGF- but are not susceptible to induction of apoptosis because
of the autocrine FGF-2 stimulation. TGF- is present in conventional cell culture and, in vivo, in
the epidermis. Supportive factors from epidermal keratinocytes explain melanocyte survival in
vivo but it is not clear what protects them from TGF- induced apoptosis in conventional
culture. The contact to cell culture plate (or to BM in vivo) might generate integrin mediated
signals that counteract the TGF- effect.
Transforming growth factor -induced apoptosis of melanocytes involves
downregulation of Bcl-2 and production of reactive oxygen species
TGF-induced apoptosis of melanocytes in collagen gel is associated with an increase in
intracellular oxidative activity and can be inhibited by antioxidants
Intracellular accumulation of reactive oxygen species (ROS) has been shown to take place in
several cases of TGF induced apoptosis (Islam et al., 1997; Kayanoki et al., 1994; Lafon et
al., 1996; Sanchez et al., 1996). To study whether ROS have a role in melanocyte apoptosis, the
level of oxidative stress was monitored using a fluorescent marker, dichlorofluorescin diacetate
(DCFH-DA). DCFH-DA is cell permeable and non-fluorescent in its reduced state but becomes
less permeable and strongly fluorescent dichlorofuorescein (DCF) once hydrolyzed by
intracellular esterases and oxidized by intracellular radicals (Bass et al., 1982; LeBel et al.,
1992).
It was found that TGF triggered apoptosis of melanocytes in collagen is accompanied by
upregulation of intracellular oxidative potential in an early phase (V). The effect was detectable
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already 4 hours after the transfer of cells to collagen (endogenous TGF stimulation; IV) and it
was stronger if exogenous TGF was added to the gel. The early detection of ROS virtually
rules out the possibility that ROS production is merely a secondary phenomenon that
accompanies cell lysis. Interestingly, no enhancement of ROS generation in response to TGF
treatment could be detected when the cells were cultured on cell culture plates suggesting that
collagen environment is a prerequisite for this effect (V).
To determine whether ROS have a causative role in melanocyte apoptosis, the cells were
cultured in collagen gel in the presence of NAC or ascorbic acid. NAC is a glutathione precursor
as well as a radical scavenger, while ascorbic acid can act as an intracellular radical scavenger
and is needed during “recycling” of oxidized vitamin E. As quantitated by TUNEL staining and
nuclear morphology, the antioxidants were effective in inhibiting TGF induced apoptosis of
melanocytes (V). FACS analysis of DCFH-DA treated cells revealed that the antioxidants
downregulated the intracellular levels of ROS (V). A time-course experiment showed that NAC
could be added 4 hours after TGF and it still had the same rescue effect, while when added 8
hours after TGF- NAC could only rescue about half of the cells (unpublished data). This
suggests that after 4-8 h of TGF- induced ROS activity the cells start passing the “point of not
return” possibly represented by activation of the terminal caspases.
TGF and FGF-2 have opposite effects on ROS generation and Bcl-2 expression of
melanocytes
FGF-2 acts as a survival factor for melanocytes in collagen gel and it can effectively inhibit
TGF induced apoptosis (IV). To study whether FGF-2 also could inhibit TGF induced
accumulation of intracellular ROS, their generation was measured utilizing DCFH-DA. FGF-2
treatment diminished ROS generation in collagen in the absence and presence of added
exogenous TGF-. However, while antioxidants NAC and ascorbic acid reduce the measurable
ROS activity also in cells growing on conventional cell culture plates, FGF-2 had little effect on
them (V). These results suggest an indirect mode of action for FGF-2 as an inhibitor of ROS
production rather than a radical scavenger.
The induction of apoptosis by TGF has in some cases been attributed to regulation of the
expression of the Bcl-2 family of proteins. Downregulation of the antiapoptotic Bcl-2 and
upregulation of some proapoptotic family members has been described (Salzman et al., 1998).
On the other hand, also FGF-2 is known in many cases to regulate the Bcl-2-related proteins.
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Recent reports have suggested an important role for Bcl-2 in regulating ROS production during
apoptosis (Cai and Jones, 1998).
To study the level of Bcl-2 protein in melanocytes, FACS analysis of fixed, antibody stained
cells was performed. Bcl-2 protein was less abundant in cells that grow in collagen than in
control cells. Exogenous TGF caused further downregulation of Bcl-2 protein. FGF-2
upregulated the level of Bcl-2 in melanocytes grown in collagen gel and it almost completely
counteracted the downregulation observed as a result of TGF addition (V).
Caspase inhibitors slow down melanocyte apoptosis in collagen without affecting ROS
generation or Bcl-2 expression
Activation of a specific set of intracellular proteases, caspases, is considered one of the most
uniform phenomena of apoptotic cell death (see Los et al., 1999; Wolf and Green, 1999 for
recent review). To study the involvement of caspases in TGF induced death of melanocytes, a
set of inhibitor peptides was used. TUNEL staining showed that two of the inhibitors,
Z-VAD-FMK and Z-DEVD-FMK, were able to inhibit the apoptosis of melanocytes in
collagen gel (V). Both are known to inhibit some of the executioner caspases that are necessary
for completing the apoptotic sequence (Los et al., 1999). In contrast, no effect on cell death was
seen by the third inhibitor used, Ac-AAVALLPAVLLALLAP-YVAD-CHO, that specifically
inhibits caspases 1 and 4. These caspases are involved in processing of certain cytokines and in
the regulation of the immune response. However, apoptosis is almost unaffected in caspase 1
knockout mice, which suggests that it is dispensable for at least some forms of apoptosis (Li et
al., 1995; Kuida et al., 1995).
The effect of caspase inhibitors on ROS accumulation and Bcl-2 expression in the presence of
TGF- was determined to further clarify the role of caspases in melanocyte apoptosis. The
inhibitors had no effect on either indicating that caspase activation takes place downstream of
Bcl-2 regulation and ROS production or is not related to them (V).
TGF cannot induce apoptosis or ROS production in the presence of the translation
inhibitor cycloheximide
To find out whether CHX inhibits melanocyte apoptosis, the cells were cultured in collagen gel
in the presence of TGF and CHX. Apoptosis was quantitated by TUNEL staining. Although
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most cells rounded up and lost their typical morphology they remained viable and showed no
DNA strand breaks (V).
FACS analysis of DCFH-DA treated cells was carried out in the presence of CHX to study
whether its antiapoptotic effect is attributable to inhibition of ROS generation. Decreased
production of oxidized, fluorescent derivatives indicated that the oxidative potential of
melanocytes is depressed by CHX treatment (V). This suggests that CHX inhibits the apoptotic
cascade very early, upstream of the production of ROS.
Cycloheximide (CHX) can inhibit TGF-induced apoptosis in several cell systems
(Yanagihara and Tsumaraya, 1992; Weller et al., 1994; Sanchez et al., 1997). Since CHX is an
inhibitor of protein synthesis, it has been proposed that the synthesis of an as yet unknown
protein is needed.
Concluding remarks
Apoptosis is induced in differentiated Tera-2 cells and normal melanocytes when grown in
collagen. In Tera-2 cells transfer to collagen causes downregulation of endogenous FGF-2
expression. Integrin mediated signals not generated in collagen gel might be needed for
sustained FGF-2 expression and autostimulation. Melanocytes do not normally produce
significant amounts of FGF-2. Nevus cells that, according to the results presented in this thesis,
have acquired an autocrine FGF-2 loop, have the ability to survive in collagen and, in vivo, in
the dermis. A recent study that employed gene transfection to overexpress FGF-2 confirmed
that FGF-2 expression induces nevus-like phenotype in melanocytes. When injected to the
dermis of human skin grafted to mice, the FGF-2 expressing transfectants survived much like
nevus cells, while control melanocytes showed rapid cell death (Nesbit et al., 1999).
Analogously, forced overexpression of FGF-2 in nontumorigenic radial growth phase
melanoma cells was shown to enable them to invade to the dermis in a skin reconstruct and to
cause tumors in SCID mice (Meier et al., 2000). Inhibition of FGF-2 or its receptor with
antisense oligonucleotides has been shown to inhibit melanoma growth both by slowing down
the proliferation of melanoma cells and by restricting tumor induced angiogenesis (Becker et
al., 1992; Wang and Becker, 1997). These results verify the significance of FGF-2 as a growth
and survival factor during both normal and abnormal growth of melanocytes.
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Endogenous TGF- mediates the apoptosis of melanocytes in collagen gel. The subcellular
mechanisms of TGF- induced apoptosis remain partly undiscovered. Melanocytes respond to
TGF- stimulation differently in different growth environments. When the cells are in contact
with a conventional cell culture plate, TGF- inhibits their growth but does not accelerate their
apoptosis. Only when the cells are grown inside a three-dimensional collagen gel can TGF-
induce their apoptosis. According to a recent study, TGF- increases glioma cell expression of
2 integrin that, together with 1, is one of the most important integrin receptors for collagen
(Miyake et al., 2000). This may suggest that 2 integrin mediated stimulation triggered by
collagen and enforced by TGF- is responsible for melanocyte apoptosis. However, this is not
supported by the facts that melanocyte
apoptosis in collagen is not affected by
antibodies to integrin 1, the counterpart of
2 in collagen receptors, or cytochalacin D
(Alanko and Saksela, unpublished data) that
disrupts the cells’ cytoskeleton and blocks
most of the signaling cascades downstream of
integrins.
The results presented in this thesis indicate
that TGF- induced apoptosis is
accompanied by early upregulation of
intracellular oxidative stress. Although
considered merely a secondary phenomenon
by some investigators, increasing evidence
points to a central role for oxidative stress in
apoptotic death. A hypothetical model
describing possible mechanisms of FGF-2
and TGF- action has been developed based
on this thesis and recent publications (Fig. 6).
According to this model, TGF- acts
primarily by downregulating the expression
of Bcl-2, which is thought to have a pivotal
role in deciding whether a cell will live or die
(Gross et al., 1999). Bcl-2 maintains the
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Figure 6. A hypothetical model of TGF- induced
apoptosis. TGF- downregulates Bcl-2 that is a universal
inhibitor of apoptosis. Loss of Bcl-2 leads to an inbalance
between pro- and antiapoptotic Bcl-2 family members.
Cytochrome c released frommitochondria associateswith
cytosolic Apaf 1 and dATP unmasking the Apaf 1 caspase
recruitment domain (CARD). Procaspase 9 binds to the
complex through CARD/CARD interaction and is
activated. Cytochrome c loss from the mitochondria leads
to production of ROS. ROS can induce apoptosis by
damaging vital structures. DNA damage induces p53
dependent apoptosis. ROS induced opening of the
mitochondrial transition pore (MPT) could lead to release
of the apoptosis inducing factor (AIF). There is no
evidence that ROS can directly activate caspases. FGF-2
effectively inhibits TGF--induced apoptosis by
upregulating Bcl-2 and possibly by other mechanisms
such as the induction of cellular antioxidants and
inhibition of caspase activation. Based on V; Cai and
Jones, 1998; Gross et al., 1999; Los et al., 1999.
integrity of the outer mitochondrial membrane. Its downregulation leads to leakage of
cytochrome c from mitochondria through the action of proapoptotic Bcl-2 family members.
Together with cytosolic Apaf 1 and dATP, cytochrome c activates caspase 9, which initiates the
caspase cascade (Los et al., 1999). Cytochrome c is an integral part of the mitochondrial
electron transport chain. Its loss from the intermembrane space of mitochondria leads to
generation of superoxide and increased oxidative stress (Cai and Jones, 1998).
The functions of ROS inside the cell are largely unknown. They are known to cause damage to
biological membranes and DNA. ROS may also trigger the opening of mitochondrial
permeability transition pore, which has been reported to augment mitochondrial dysfunction
and release proteins, including the apoptosis inducing factor to the cytosol (Hirsch et al., 1997;
Susin et al., 1996; Zoratti and Szabo, 1995). The mechanism, by which antioxidants block
apoptosis, is currently unknown. ROS are not known to be able to activate caspases. It is clear
that several links are still lacking from this model.
The model suggests that FGF-2 acts by upregulating Bcl-2 expression. FGF-2 probably has
additional functions that inhibit apoptosis. It is tempting to speculate that FGF-2 regulates the
expression of IAP. VEGF, that functions as a survival factor for vascular endothelial cells in a
similar fashion as FGF-2, has been shown to induce the expression of IAPs survivin and XIAP
in them (Tran et al., 1999). IAP can inhibit apoptosis even after activation of the effector
caspases. A recent study reported that survivin is expressed by human nevus and melanoma
cells but not by normal melanocytes, which could make it a potential target for novel anticancer
therapies (Grossman et al., 1999).
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PERSPECTIVE
This study reports the development of a novel method to monitor migration, growth, and
apoptosis of cells in three-dimensional culture. The results provide new insights into the biology
of the developing nervous system and skin. Differentiation of Tera-2 cells into neuron-like cells
was found to be accompanied by a change in their ability to migrate through three-dimensional
ECM, in their apoptotic potential, and requirement for stimulating growth factors. It is still not
known what the actual targets and mechanisms of FGF-2 action in vivo are. Since apoptosis
depends on the surrounding ECM and it has been previously shown that FGF-2 can stimulate
the cell surface proteolysis, a change in interactions with matrix through integrins or other
specialized molecules might be involved. FGF-2 has been used experimentally to stimulate the
regeneration and inhibit apoptosis of axotomized neurons in vivo.
Differences in growth requirements between human skin melanocytes, dermal nevus cells, and
melanoma cells were studied. Collagen gel was used as a model of dermis, a natural
environment for nevus cells and metastatic melanoma cells, but not for normal skin
melanocytes. FGF-2 and TGF were found to act as antagonists as they regulate the apoptosis
of normal melanocytes. Endogenous TGF expression was found to be capable of inducing
apoptosis of melanocytes in collagen. Nevus cells have strong endogenous FGF-2 stimulation
and, thus, were protected from apoptosis in collagen gel. They were sensitive to growth
inhibition but not apoptosis mediated by TGF. Melanoma cells, on the other hand, were
totally unresponsive to TGF. They also exhibited strong FGF-2 expression but in their case
FGF-2 probably acts less as a survival factor and more as a stroma stimulating and angiogenic
factor, since most melanomas express a multitude of growth stimulatory mutations. The role of
FGF-2 in melanoma development, growth and metastasis is a subject that has gained much
interest. Several recent publications have confirmed the results presented in this thesis (Nesbit
et al., 1999; Meier et al., 2000).
The nature of TGF-induced apoptosis was further characterized. It was found that TGF
stimulation is accompanied by an upregulated level of intracellular oxidative stress in
melanocytes. ROS level was downregulated by FGF-2, antioxidants, and CHX, all inhibitors of
melanocyte apoptosis. The fact that antioxidants could inhibit melanocyte apoptosis suggests
that ROS are needed for apoptosis. On the other hand, caspase inhibitors inhibited apoptosis
without affecting ROS level, showing that elevated ROS production is not sufficient for
apoptosis. It seems that ROS act upstream of caspases and perhaps are even able to activate the
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caspase cascade, but the necessary cofactors are not known and the subject requires further
investigation.
TGF and FGF-2 had antagonistic effect on Bcl-2 expression also. Bcl-2 has been suggested
to act as a regulator of intracellular ROS production. The results presented here are consistent
with this theory but are not conclusive. Further clarification could be obtained by transfection
experiments using an inducible Bcl-2 expression vector construct and by studying the integrity
of the mitochondrial membranes utilizing suitable fluorescent markers. The effect of TGF
and FGF-2 on the expression of cellular antioxidants like superoxide dismutase, catalase and
glutathione peroxidase should also be studied.
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